or, select a GWAS: 5-HTT brain serotonin transporter levels (Liu X, 2011, 1 SNP) AB1-42 (Han MR, 2010, 7 SNPs, EUR) Abdominal aortic aneurysm (3 loci from 2 studies in EUR) Abdominal aortic aneurysm (Bown MJ, 2011, 1 SNP, EUR) Abdominal aortic aneurysm (Gretarsdottir S, 2010, 2 SNPs, EUR) Acenocoumarol maintenance dosage (Teichert M, 2009, 4 SNPs, EUR) Activated partial thromboplastin time (Houlihan LM, 2010, 3 SNPs, EUR) Activated partial thromboplastin time (Tang W, 2012, 9 SNPs, EUR) Acute lymphoblastic leukemia (childhood) (29 loci from 4 studies in EUR) Acute lymphoblastic leukemia (childhood) (Ellinghaus E, 2011, 11 SNPs, EUR) Acute lymphoblastic leukemia (childhood) (Papaemmanuil E, 2009, 3 SNPs, EUR) Acute lymphoblastic leukemia (childhood) (Trevino LR, 2009, 14 SNPs, EUR) Acute lymphoblastic leukemia (childhood) (Xu H, 2013, 3 SNPs) Acute lymphoblastic leukemia (childhood) (Yang JJ, 2012, 10 SNPs, EUR) Addiction (Liu Z, 2013, 3 SNPs, EUR) Adiponectin levels (34 loci from 5 studies in EUR) Adiponectin levels (4 loci from 3 studies in ASN) Adiponectin levels (Chung CM, 2011, 1 SNP, ASN) Adiponectin levels (Dastani Z, 2012, 31 SNPs, EUR) Adiponectin levels (Heid IM, 2009, 1 SNP, EUR) Adiponectin levels (Jee SH, 2010, 1 SNP, ASN) Adiponectin levels (Ling H, 2009, 2 SNPs, EUR) Adiponectin levels (Morisaki H, 2011, 1 SNP, ASN) Adiponectin levels (Qi L, 2011, 5 SNPs, EUR) Adiponectin levels (Richards JB, 2009, 3 SNPs, EUR) Adiponectin levels (Wu Y, 2010, 3 SNPs, ASN) Adiposity (7 loci from 3 studies in EUR) Adiposity (Kilpelainen TO, 2011, 3 SNPs, EUR) Adiposity (Lindgren CM, 2009, 4 SNPs, EUR) Adiposity (Plourde M, 2012, 1 SNP, EUR) Adiposity in newborns (Urbanek M, 2013, 4 SNPs) Adverse response to aromatase inhibitors (Ingle JN, 2010, 1 SNP, EUR) Adverse response to aromatase inhibitors (Ingle JN, 2010, 1 SNP, EUR) Adverse response to carbamapezine (McCormack M, 2011, 1 SNP, EUR) Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (Low SK, 2013, 4 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs) (Low SK, 2013, 6 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs) (Low SK, 2013, 6 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs) (Low SK, 2013, 12 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs) (Low SK, 2013, 6 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors) (Low SK, 2013, 6 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin) (Low SK, 2013, 3 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin) (Low SK, 2013, 9 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin) (Low SK, 2013, 7 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide) (Low SK, 2013, 3 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel) (Low SK, 2013, 7 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin) (Low SK, 2013, 3 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin) (Low SK, 2013, 5 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide) (Low SK, 2013, 4 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine) (Low SK, 2013, 5 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin) (Low SK, 2013, 7 SNPs, ASN) Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel) (Low SK, 2013, 8 SNPs, ASN) Adverse response to lamotrigine and phenytoin (McCormack M, 2012, 12 SNPs, EUR) Adverse response to radiation therapy (Kerns SL, 2013, 3 SNPs) Age-related macular degeneration (52 loci from 7 studies in EUR) Age-related macular degeneration (Arakawa S, 2011, 2 SNPs, ASN) Age-related macular degeneration (Chen W, 2010, 12 SNPs, EUR) Age-related macular degeneration (Cipriani V, 2012, 6 SNPs, EUR) Age-related macular degeneration (CNV vs. GA) (Sobrin L, 2012, 1 SNP, EUR) Age-related macular degeneration (CNV) (Sobrin L, 2012, 6 SNPs, EUR) Age-related macular degeneration (extreme sampling) (Naj AC, 2013, 3 SNPs, EUR) Age-related macular degeneration (Fritsche LG, 2013, 19 SNPs, EUR) Age-related macular degeneration (GA) (Sobrin L, 2012, 9 SNPs, EUR) Age-related macular degeneration (Holliday EG, 2013, 30 SNPs, EUR) Age-related macular degeneration (Klein RJ, 2005, 1 SNP, EUR) Age-related macular degeneration (Kopplin LJ, 2010, 4 SNPs, EUR) Age-related macular degeneration (Naj AC, 2013, 5 SNPs, EUR) Age-related macular degeneration (Neale BM, 2010, 11 SNPs, EUR) Age-related macular degeneration (Scheetz TE, 2013, 2 SNPs, EUR) Age-related macular degeneration (smoking status interaction) (Naj AC, 2013, 3 SNPs, EUR) Age-related macular degeneration (wet) (Dewan A, 2006, 1 SNP) Age-related macular degeneration (Yu Y, 2011, 11 SNPs, EUR) Aging (9 loci from 2 studies in EUR) Aging (Edwards DR, 2012, 8 SNPs, EUR) Aging (facial) (Le Clerc S, 2012, 4 SNPs, EUR) Aging (Poduslo SE, 2009, 1 SNP, EUR) Aging (time to death) (Walter S, 2011, 3 SNPs, EUR) Aging (time to event) (Walter S, 2011, 8 SNPs, EUR) Aging traits (Lunetta KL, 2007, 10 SNPs, EUR) AIDS (Le Clerc S, 2009, 7 SNPs, EUR) AIDS progression (9 loci from 2 studies in EUR) AIDS progression (Limou S, 2009, 3 SNPs, EUR) AIDS progression (Troyer JL, 2011, 7 SNPs, EUR) Airflow obstruction (Wilk JB, 2012, 30 SNPs, EUR) Alcohol and nictotine co-dependence (Zuo L, 2012, 2 SNPs, EUR) Alcohol and nictotine co-dependence (Zuo L, 2012, 8 SNPs) Alcohol consumption (Baik I, 2011, 4 SNPs, ASN) Alcohol consumption (Schumann G, 2011, 1 SNP, EUR) Alcohol consumption (transferrin glycosylation) (Kutalik Z, 2011, 6 SNPs, EUR) Alcohol dependence (20 loci from 7 studies in EUR) Alcohol dependence (Frank J, 2011, 6 SNPs, EUR) Alcohol dependence (Kendler KS, 2011, 3 SNPs, EUR) Alcohol dependence (Lydall GJ, 2011, 1 SNP, EUR) Alcohol dependence (Park BL, 2013, 1 SNP, ASN) Alcohol dependence (Treutlein J, 2009, 6 SNPs, EUR) Alcohol dependence (Wang KS, 2011, 2 SNPs, EUR) Alcohol dependence (Zuo L, 2011, 3 SNPs, EUR) Alcohol dependence (Zuo L, 2013, 1 SNP, EUR) Alcoholism (12-month weekly alcohol consumption) (Heath AC, 2011, 2 SNPs, EUR) Alcoholism (alcohol dependence factor score) (Heath AC, 2011, 6 SNPs, EUR) Alcoholism (alcohol use disorder factor score) (Heath AC, 2011, 6 SNPs, EUR) Alcoholism (heaviness of drinking) (Heath AC, 2011, 8 SNPs, EUR) Allergic rhinitis (Ramasamy A, 2011, 9 SNPs, EUR) Alopecia areata (Petukhova L, 2010, 8 SNPs, EUR) Alzheimer's disease (28 loci from 9 studies in EUR) Alzheimer's disease (Abraham R, 2008, 2 SNPs, EUR) Alzheimer's disease (age of onset) (Kamboh MI, 2011, 12 SNPs, EUR) Alzheimer's disease (Antunez C, 2011, 5 SNPs, EUR) Alzheimer's disease (Beecham GW, 2009, 3 SNPs, EUR) Alzheimer's disease (Bertram L, 2008, 2 SNPs, EUR) Alzheimer's disease (Carrasquillo MM, 2009, 1 SNP, EUR) Alzheimer's disease (cognitive decline) (Sherva R, 2013, 44 SNPs, EUR) Alzheimer's disease (Feulner TM, 2009, 1 SNP, EUR) Alzheimer's disease (Harold D, 2009, 3 SNPs, EUR) Alzheimer's disease (Heinzen EL, 2009, 5 SNPs) Alzheimer's disease (Hollingworth P, 2011, 18 SNPs) Alzheimer's disease (Hollingworth P, 2011, 4 SNPs, EUR) Alzheimer's disease (Kamboh MI, 2012, 8 SNPs, EUR) Alzheimer's disease (Kramer PL, 2010, 2 SNPs, EUR) Alzheimer's disease (Lambert JC, 2009, 3 SNPs, EUR) Alzheimer's disease (Lambert JC, 2012, 1 SNP, EUR) Alzheimer's disease (late onset) (30 loci from 6 studies in EUR) Alzheimer's disease (late onset) (Coon KD, 2007, 1 SNP) Alzheimer's disease (late onset) (Cummings AC, 2012, 13 SNPs, EUR) Alzheimer's disease (late onset) (Hu X, 2011, 2 SNPs, EUR) Alzheimer's disease (late onset) (Miyashita A, 2013, 2 SNPs, ASN) Alzheimer's disease (late onset) (Naj AC, 2010, 4 SNPs, EUR) Alzheimer's disease (late onset) (Naj AC, 2011, 9 SNPs, EUR) Alzheimer's disease (late onset) (Reiman EM, 2007, 1 SNP, EUR) Alzheimer's disease (late onset) (Reitz C, 2013, 2 SNPs, AFR) Alzheimer's disease (late onset) (Wijsman EM, 2011, 1 SNP, EUR) Alzheimer's disease (Li H, 2007, 1 SNP, EUR) Alzheimer's disease (Logue MW, 2011, 11 SNPs, AFR) Alzheimer's disease (Meda SA, 2012, 2 SNPs, EUR) Alzheimer's disease (Seshadri S, 2010, 1 SNP, EUR) Alzheimer's disease (Webster JA, 2007, 1 SNP) Alzheimer's disease biomarkers (20 loci from 3 studies in EUR) Alzheimer's disease biomarkers (Cruchaga C, 2013, 6 SNPs, EUR) Alzheimer's disease biomarkers (Kim S, 2010, 7 SNPs, EUR) Alzheimer's disease biomarkers (Ramanan VK, 2013, 13 SNPs, EUR) Amyloid A Levels (Marzi C, 2010, 3 SNPs, EUR) Amyotrophic lateral sclerosis (47 loci from 9 studies in EUR) Amyotrophic lateral sclerosis (age of onset) (Ahmeti KB, 2012, 13 SNPs, EUR) Amyotrophic lateral sclerosis (Ahmeti KB, 2012, 15 SNPs, EUR) Amyotrophic lateral sclerosis (Blauw HM, 2008, 1 SNP) Amyotrophic lateral sclerosis (Cronin S, 2007, 1 SNP, EUR) Amyotrophic lateral sclerosis (Cronin S, 2008, 1 SNP, EUR) Amyotrophic lateral sclerosis (Deng M, 2013, 2 SNPs, ASN) Amyotrophic lateral sclerosis (Kwee LC, 2012, 2 SNPs, EUR) Amyotrophic lateral sclerosis (Laaksovirta H, 2010, 2 SNPs, EUR) Amyotrophic lateral sclerosis (Landers JE, 2009, 16 SNPs, EUR) Amyotrophic lateral sclerosis (Schymick JC, 2007, 6 SNPs, EUR) Amyotrophic lateral sclerosis (Shatunov A, 2010, 4 SNPs, EUR) Amyotrophic lateral sclerosis (van Es MA, 2007, 1 SNP, EUR) Amyotrophic lateral sclerosis (van Es MA, 2007, 3 SNPs, EUR) Amyotrophic lateral sclerosis (van Es MA, 2009, 8 SNPs, EUR) Androgen levels (Jin G, 2012, 6 SNPs, EUR) Angiotensin-converting enzyme activity (Chung CM, 2010, 2 SNPs, ASN) Ankle-brachial index (Murabito JM, 2011, 2 SNPs, EUR) Ankylosing spondylitis (19 loci from 2 studies in EUR) Ankylosing spondylitis (Evans DM, 2011, 13 SNPs, EUR) Ankylosing spondylitis (Lin Z, 2011, 5 SNPs, ASN) Ankylosing spondylitis (Reveille JD, 2010, 9 SNPs, EUR) Anorexia nervosa (23 loci from 2 studies in EUR) Anorexia nervosa (Wade TD, 2013, 15 SNPs, EUR) Anorexia nervosa (Wang K, 2010, 9 SNPs, EUR) Anthropometric traits (Polasek O, 2009, 13 SNPs, EUR) Anti-cyclic Citrullinated Peptide Antibody (Cui J, 2009, 1 SNP, EUR) Anticoagulant levels (Athanasiadis G, 2011, 8 SNPs, EUR) Antineutrophil cytoplasmic antibody-associated vasculitis (Lyons PA, 2012, 18 SNPs, EUR) Antipsychotic drug-induced weight gain (Malhotra AK, 2012, 1 SNP) Antipsychotic-induced QTc interval prolongation (Aberg K, 2010, 3 SNPs) Aortic root size (Vasan RS, 2009, 6 SNPs, EUR) Aortic root size (Wineinger NE, 2011, 7 SNPs, AFR) Aortic stiffness (Mitchell GF, 2011, 1 SNP, EUR) Aortic-valve calcification (Thanassoulis G, 2013, 1 SNP, EUR) Apolipoprotein Levels (Surakka I, 2012, 3 SNPs, EUR) Arterial stiffness (Tarasov KV, 2009, 1 SNP, EUR) Arthritis (juvenile idiopathic) (5 loci from 2 studies in EUR) Arthritis (juvenile idiopathic) (Behrens EM, 2008, 1 SNP) Arthritis (juvenile idiopathic) (Hinks A, 2009, 1 SNP, EUR) Arthritis (juvenile idiopathic) (Thompson SD, 2012, 4 SNPs, EUR) Asparaginase hypersensitivity in acute lymphoblastic leukemia (Chen SH, 2010, 1 SNP, EUR) Aspartate aminotransferase (Shen H, 2011, 1 SNP, EUR) Asperger disorder (Salyakina D, 2010, 5 SNPs, EUR) Aspirin exacerbated respiratory disease in asthmatics (Park BL, 2012, 1 SNP, ASN) Aspirin hydrolysis (plasma) (Zhou G, 2013, 1 SNP, EUR) Asthma (15 loci from 2 studies in ASN) Asthma (25 loci from 9 studies in EUR) Asthma (bronchodilator response) (3 loci from 2 studies in EUR) Asthma (bronchodilator response) (Duan QL, 2013, 2 SNPs, EUR) Asthma (bronchodilator response) (Himes BE, 2012, 1 SNP, EUR) Asthma (childhood onset) (Forno E, 2012, 5 SNPs, EUR) Asthma (childhood onset) (Hancock DB, 2009, 1 SNP, AMR) Asthma (Ferreira MA, 2010, 1 SNP, EUR) Asthma (Ferreira MA, 2011, 4 SNPs, EUR) Asthma (Himes BE, 2009, 1 SNP) Asthma (Hirota T, 2011, 14 SNPs, ASN) Asthma (Lasky-Su J, 2012, 1 SNP, EUR) Asthma (Li X, 2010, 3 SNPs, EUR) Asthma (Moffatt MF, 2007, 1 SNP, EUR) Asthma (Moffatt MF, 2010, 10 SNPs, EUR) Asthma (Noguchi E, 2011, 2 SNPs, ASN) Asthma (Ramasamy A, 2012, 2 SNPs, EUR) Asthma (Sleiman PM, 2009, 1 SNP, EUR) Asthma (Tantisira KG, 2012, 1 SNP, EUR) Asthma (toluene diisocyanate-induced) (Kim SH, 2009, 3 SNPs, ASN) Asthma (Torgerson DG, 2011, 7 SNPs) Asthma (Wan YI, 2012, 7 SNPs, EUR) Atopic dermatitis (18 loci from 2 studies in ASN) Atopic dermatitis (7 loci from 2 studies in EUR) Atopic dermatitis (Esparza-Gordillo J, 2009, 1 SNP, EUR) Atopic dermatitis (Hirota T, 2012, 17 SNPs, ASN) Atopic dermatitis (Paternoster L, 2011, 6 SNPs, EUR) Atopic dermatitis (Sun LD, 2011, 1 SNP, ASN) Atopy (Castro-Giner F, 2009, 1 SNP, EUR) Atrial fibrillation (16 loci from 4 studies in EUR) Atrial fibrillation (Benjamin EJ, 2009, 3 SNPs, EUR) Atrial fibrillation (Ellinor PT, 2010, 3 SNPs, EUR) Atrial fibrillation (Ellinor PT, 2012, 10 SNPs, EUR) Atrial fibrillation (Gudbjartsson DF, 2009, 2 SNPs, EUR) Atrial fibrillation (Larson MG, 2007, 3 SNPs, EUR) Atrial fibrillation/atrial flutter (Gudbjartsson DF, 2007, 2 SNPs, EUR) Atrioventricular conduction (Denny JC, 2010, 5 SNPs, EUR) Attention deficit hyperactivity disorder (66 loci from 6 studies in EUR) Attention deficit hyperactivity disorder (combined symptoms) (Ebejer JL, 2013, 21 SNPs) Attention deficit hyperactivity disorder (Hinney A, 2011, 2 SNPs, EUR) Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms) (Ebejer JL, 2013, 25 SNPs) Attention deficit hyperactivity disorder (inattention symptoms) (Ebejer JL, 2013, 22 SNPs) Attention deficit hyperactivity disorder (Lasky-Su J, 2008, 19 SNPs, EUR) Attention deficit hyperactivity disorder (Lesch KP, 2008, 26 SNPs, EUR) Attention deficit hyperactivity disorder (Mick E, 2008, 2 SNPs) Attention deficit hyperactivity disorder (Mick E, 2010, 10 SNPs, EUR) Attention deficit hyperactivity disorder (Mick E, 2011, 7 SNPs, EUR) Attention deficit hyperactivity disorder (Neale BM, 2010, 5 SNPs, EUR) Attention deficit hyperactivity disorder (time to onset) (Lasky-Su J, 2008, 11 SNPs, EUR) Attention deficit hyperactivity disorder (Yang L, 2013, 4 SNPs, ASN) Attention deficit hyperactivity disorder and conduct disorder (Anney RJ, 2008, 26 SNPs, EUR) Attention deficit hyperactivity disorder motor coordination (Fliers EA, 2011, 1 SNP, EUR) Attention deficit hyperactivity disorder symptoms (interaction) (Sonuga-Barke EJ, 2008, 7 SNPs, EUR) Autism (8 loci from 4 studies in EUR) Autism (Anney R, 2010, 2 SNPs, EUR) Autism (Anney R, 2012, 4 SNPs, EUR) Autism (Ma D, 2009, 1 SNP, EUR) Autism (Wang K, 2009, 1 SNP, EUR) Autism (Weiss LA, 2009, 1 SNP) Autism, ADHD, bipolar, major depression, and schizophrenia (combined) (Smoller JW, 2013, 74 SNPs, EUR) B cell non-Hodgkin lymphoma (Tan DE, 2013, 1 SNP, ASN) B2-Glycoprotein I (B2-GPI) plasma levels (Athanasiadis G, 2013, 9 SNPs, EUR) Barrett's esophagus (Su Z, 2012, 5 SNPs, EUR) Basal cell carcinoma (5 loci from 2 studies in EUR) Basal cell carcinoma (Nan H, 2011, 3 SNPs, EUR) Basal cell carcinoma (Stacey SN, 2008, 2 SNPs, EUR) Behcet's disease (7 loci from 2 studies in ASN) Behcet's disease (7 loci from 2 studies in EUR) Behcet's disease (Hou S, 2012, 6 SNPs, ASN) Behcet's disease (Kirino Y, 2013, 6 SNPs, EUR) Behcet's disease (Mizuki N, 2010, 2 SNPs, ASN) Behcet's disease (Remmers EF, 2010, 2 SNPs, EUR) Beta thalassemia/hemoglobin E disease (Nuinoon M, 2009, 3 SNPs, ASN) Beta-2 microglubulin plasma levels (Tin A, 2013, 16 SNPs, EUR) Beta-trace protein levels (Tin A, 2013, 1 SNP, EUR) Biliary atresia (Garcia-Barcelo MM, 2010, 3 SNPs, ASN) Bilirubin levels (10 loci from 2 studies in ASN) Bilirubin levels (12 loci from 3 studies in EUR) Bilirubin levels (Bielinski SJ, 2011, 5 SNPs, EUR) Bilirubin levels (Chen G, 2011, 9 SNPs, AFR) Bilirubin levels (Cox AJ, 2013, 1 SNP, EUR) Bilirubin levels (Dai X, 2013, 10 SNPs, ASN) Bilirubin levels (Johnson AD, 2009, 8 SNPs, EUR) Bilirubin levels (Kang TW, 2010, 14 SNPs, ASN) Bilirubin levels (Sanna S, 2009, 3 SNPs, EUR) Biochemical measures (Zemunik T, 2009, 17 SNPs, EUR) Biomedical quantitative traits (Cho YS, 2009, 8 SNPs, ASN) Bipolar disorder (100 loci from 13 studies in EUR) Bipolar disorder (age of onset and psychomotor symptoms) (Belmonte Mahon P, 2011, 2 SNPs, EUR) Bipolar disorder (Baum AE, 2007, 1 SNP, EUR) Bipolar disorder (Bergen SE, 2012, 4 SNPs, EUR) Bipolar disorder (Chen DT, 2011, 5 SNPs, EUR) Bipolar disorder (Cichon S, 2011, 1 SNP, EUR) Bipolar disorder (Ferreira MA, 2008, 21 SNPs, EUR) Bipolar disorder (Jiang Y, 2011, 24 SNPs, EUR) Bipolar disorder (Kerner B, 2011, 3 SNPs, EUR) Bipolar disorder (Lee HJ, 2012, 15 SNPs, EUR) Bipolar disorder (Lee MT, 2010, 2 SNPs, ASN) Bipolar disorder (mania) (Greenwood TA, 2013, 1 SNP, EUR) Bipolar disorder (mood-incongruent) (Goes FS, 2012, 16 SNPs, EUR) Bipolar disorder (Scott LJ, 2009, 13 SNPs, EUR) Bipolar disorder (Sklar P, 2011, 18 SNPs, EUR) Bipolar disorder (Smith EN, 2009, 1 SNP) Bipolar disorder (Smith EN, 2011, 6 SNPs, EUR) Bipolar disorder (WTCCC, 2007, 7 SNPs, EUR) Bipolar disorder (Yosifova A, 2011, 3 SNPs, EUR) Bipolar disorder (Zhang D, 2008, 1 SNP, EUR) Bipolar disorder and major depressive disorder (combined) (Liu Y, 2010, 9 SNPs, EUR) Bipolar disorder and schizophrenia (112 loci from 3 studies in EUR) Bipolar disorder and schizophrenia (Bergen SE, 2012, 13 SNPs, EUR) Bipolar disorder and schizophrenia (Curtis D, 2010, 6 SNPs, EUR) Bipolar disorder and schizophrenia (Wang KS, 2010, 103 SNPs, EUR) Birth weight (Freathy RM, 2010, 2 SNPs, EUR) Birth weight (Horikoshi M, 2012, 10 SNPs, EUR) Bitter taste response (Reed DR, 2010, 1 SNP, EUR) Black vs. blond hair color (Han J, 2008, 7 SNPs, EUR) Black vs. red hair color (Han J, 2008, 7 SNPs, EUR) Bladder cancer (11 loci from 3 studies in EUR) Bladder cancer (Garcia-Closas M, 2011, 1 SNP, EUR) Bladder cancer (Rafnar T, 2011, 1 SNP, EUR) Bladder cancer (Rothman N, 2010, 10 SNPs, EUR) Bladder cancer (Wu X, 2009, 1 SNP, EUR) Bleomycin sensitivity (Gu J, 2010, 3 SNPs, EUR) Blond vs. brown hair color (5 loci from 2 studies in EUR) Blond vs. brown hair color (Sulem P, 2007, 4 SNPs, EUR) Blond vs. brown hair color (Sulem P, 2008, 1 SNP, EUR) Blood pressure (12 loci from 2 studies in ASN) Blood pressure (44 loci from 3 studies in EUR) Blood pressure (Kato N, 2011, 17 SNPs, ASN) Blood pressure (Levy D, 2007, 9 SNPs, EUR) Blood pressure (Wain LV, 2011, 41 SNPs, EUR) Blood pressure (Wang Y, 2008, 1 SNP, EUR) Blood pressure (Zhang D, 2012, 4 SNPs, ASN) Blood trace element (Cu levels) (Evans DM, 2013, 7 SNPs, EUR) Blood trace element (Se levels) (Evans DM, 2013, 10 SNPs, EUR) Blood trace element (Zn levels) (Evans DM, 2013, 11 SNPs, EUR) Blue vs. brown eyes (Sulem P, 2007, 1 SNP, EUR) Blue vs. green eyes (4 loci from 2 studies in EUR) Blue vs. green eyes (Sulem P, 2007, 3 SNPs, EUR) Blue vs. green eyes (Sulem P, 2008, 1 SNP, EUR) Body mass (lean) (Guo YF, 2012, 1 SNP, ASN) Body mass (lean) (Liu XG, 2009, 1 SNP) Body mass in chronic obstructive pulmonary disease (Wan ES, 2010, 1 SNP, EUR) Body mass index (22 loci from 3 studies in ASN) Body mass index (72 loci from 9 studies in EUR) Body mass index (8 loci from 2 studies in AFR) Body mass index (asthmatics) (Melen E, 2013, 6 SNPs, EUR) Body mass index (Berndt SI, 2013, 10 SNPs, EUR) Body mass index (Croteau-Chonka DC, 2010, 6 SNPs, ASN) Body mass index (Fox CS, 2007, 3 SNPs, EUR) Body mass index (Frayling TM, 2007, 1 SNP, EUR) Body mass index (Graff M, 2013, 14 SNPs, EUR) Body mass index (interaction) (Velez Edwards DR, 2012, 15 SNPs) Body mass index (Johansson A, 2009, 10 SNPs, EUR) Body mass index (Liu JZ, 2010, 2 SNPs, EUR) Body mass index (Loos RJ, 2008, 2 SNPs, EUR) Body mass index (Monda KL, 2013, 7 SNPs, AFR) Body mass index (Ng MC, 2011, 2 SNPs, AFR) Body mass index (non-asthmatics) (Melen E, 2013, 10 SNPs, EUR) Body mass index (Okada Y, 2012, 10 SNPs, ASN) Body mass index (Speliotes EK, 2010, 38 SNPs, EUR) Body mass index (Thorleifsson G, 2008, 14 SNPs, EUR) Body mass index (Wang KS, 2012, 3 SNPs, EUR) Body mass index (Wen W, 2012, 7 SNPs, ASN) Body mass index (Willer CJ, 2008, 11 SNPs, EUR) Body mass index (Yang J, 2012, 1 SNP, EUR) Body mass index and cholesterol (psychopharmacological treatment) (Athanasiu L, 2012, 2 SNPs, EUR) Bone mineral density (29 loci from 10 studies in EUR) Bone mineral density (Duncan EL, 2011, 9 SNPs, EUR) Bone mineral density (Estrada K, 2012, 69 SNPs) Bone mineral density (Guo Y, 2009, 2 SNPs, EUR) Bone mineral density (hip) (21 loci from 3 studies in EUR) Bone mineral density (hip) (Rivadeneira F, 2009, 13 SNPs, EUR) Bone mineral density (hip) (Styrkarsdottir U, 2008, 6 SNPs, EUR) Bone mineral density (hip) (Styrkarsdottir U, 2008, 8 SNPs, EUR) Bone mineral density (Kiel DP, 2007, 8 SNPs, EUR) Bone mineral density (Kung AW, 2010, 1 SNP, ASN) Bone mineral density (Medina-Gomez C, 2012, 2 SNPs, EUR) Bone mineral density (Paternoster L, 2010, 1 SNP, EUR) Bone mineral density (Paternoster L, 2013, 7 SNPs, EUR) Bone mineral density (Richards JB, 2008, 2 SNPs, EUR) Bone mineral density (spine) (26 loci from 3 studies in EUR) Bone mineral density (spine) (Rivadeneira F, 2009, 16 SNPs, EUR) Bone mineral density (spine) (Styrkarsdottir U, 2008, 7 SNPs, EUR) Bone mineral density (spine) (Styrkarsdottir U, 2008, 8 SNPs, EUR) Bone mineral density (Xiong DH, 2009, 2 SNPs, EUR) Bone mineral density (Zheng HF, 2012, 1 SNP, EUR) Bone mineral density (Zheng HF, 2013, 1 SNP, EUR) Brachial circumference (Boraska V, 2012, 1 SNP, EUR) Brain connectivity (Jahanshad N, 2013, 12 SNPs, EUR) Brain cytoarchitecture (Kim S, 2010, 2 SNPs, EUR) Brain imaging (Shen L, 2010, 10 SNPs, EUR) Brain imaging in schizophrenia (interaction) (Potkin SG, 2008, 6 SNPs, EUR) Brain lesion load (Baranzini SE, 2008, 4 SNPs, EUR) Brain structure (21 loci from 2 studies in EUR) Brain structure (hippocampal volume) (Stein JL, 2010, 4 SNPs, EUR) Brain structure (Stein JL, 2010, 19 SNPs, EUR) Brain structure (Stein JL, 2012, 2 SNPs, EUR) Brain structure (temporal lobe volume) (Stein JL, 2010, 5 SNPs, EUR) Breast cancer (2 loci from 2 studies in AFR) Breast cancer (8 loci from 5 studies in ASN) Breast cancer (99 loci from 14 studies in EUR) Breast cancer (Antoniou AC, 2010, 1 SNP, EUR) Breast cancer (Cai Q, 2011, 2 SNPs, EUR) Breast cancer (Chen F, 2012, 1 SNP, AFR) Breast cancer (Easton DF, 2007, 6 SNPs, EUR) Breast cancer (Elgazzar S, 2012, 2 SNPs, ASN) Breast cancer (Fletcher O, 2011, 9 SNPs, EUR) Breast cancer (Garcia-Closas M, 2013, 17 SNPs, EUR) Breast cancer (Gaudet MM, 2010, 1 SNP, EUR) Breast cancer (Gold B, 2008, 1 SNP, EUR) Breast cancer (Haiman CA, 2011, 1 SNP) Breast cancer (Hunter DJ, 2007, 1 SNP, EUR) Breast cancer (Kibriya MG, 2008, 1 SNP, EUR) Breast cancer (Kim HC, 2012, 1 SNP, ASN) Breast cancer (Li J, 2010, 4 SNPs, EUR) Breast cancer (Long J, 2010, 1 SNP, ASN) Breast cancer (Long J, 2012, 3 SNPs, ASN) Breast cancer (male) (Orr N, 2012, 3 SNPs, EUR) Breast cancer (Michailidou K, 2013, 63 SNPs, EUR) Breast cancer (Murabito JM, 2007, 9 SNPs, EUR) Breast cancer (prognosis) (Rafiq S, 2013, 5 SNPs, EUR) Breast cancer (Rinella ES, 2013, 3 SNPs, EUR) Breast cancer (Sehrawat B, 2011, 2 SNPs, EUR) Breast cancer (Siddiq A, 2012, 4 SNPs, EUR) Breast cancer (Song C, 2013, 13 SNPs, AFR) Breast cancer (Stacey SN, 2007, 2 SNPs, EUR) Breast cancer (survival) (Shu XO, 2012, 3 SNPs, ASN) Breast cancer (Thomas G, 2009, 6 SNPs, EUR) Breast cancer (Turnbull C, 2010, 13 SNPs, EUR) Breast cancer (Zheng W, 2009, 1 SNP, ASN) Breast Cancer in BRCA1 mutation carriers (Couch FJ, 2013, 6 SNPs, EUR) Breast size (Eriksson N, 2012, 38 SNPs, EUR) Bulimia nervosa (Wade TD, 2013, 23 SNPs, EUR) Burning and freckling (Sulem P, 2008, 1 SNP, EUR) Butyrylcholinesterase levels (Benyamin B, 2011, 3 SNPs, EUR) C-reactive protein (26 loci from 3 studies in EUR) C-reactive protein (7 loci from 2 studies in ASN) C-reactive protein (Dehghan A, 2011, 20 SNPs, EUR) C-reactive protein (Doumatey AP, 2012, 1 SNP, AFR) C-reactive protein (Elliott P, 2009, 5 SNPs) C-reactive protein (Okada Y, 2010, 4 SNPs, ASN) C-reactive protein (Reiner AP, 2008, 3 SNPs, EUR) C-reactive protein (Reiner AP, 2012, 11 SNPs, AFR) C-reactive protein (Ridker PM, 2008, 7 SNPs, EUR) C-reactive protein (Wu Y, 2011, 3 SNPs, ASN) C-reactive protein and white blood cell count (Kong M, 2012, 9 SNPs, ASN) C4b binding protein levels (Buil A, 2010, 1 SNP, EUR) Caffeine consumption (Cornelis MC, 2011, 10 SNPs, EUR) Calcium levels (Kapur K, 2010, 1 SNP) Calcium levels (O'Seaghdha CM, 2010, 10 SNPs, EUR) Cannabis dependence (Agrawal A, 2010, 10 SNPs, EUR) Cannabis use (initiation) (Verweij KJ, 2012, 6 SNPs, EUR) Capecitabine sensitivity (O'Donnell PH, 2012, 22 SNPs, ASN) Cardiac hypertrophy (Parsa A, 2011, 19 SNPs, EUR) Cardiac repolarization (4 loci from 2 studies in EUR) Cardiac repolarization (Marjamaa A, 2012, 1 SNP, EUR) Cardiac repolarization (Sinner MF, 2012, 3 SNPs, EUR) Cardiac structure and function (Vasan RS, 2009, 4 SNPs, EUR) Cardiac Troponin-T levels (Yu B, 2012, 19 SNPs, EUR) Cardiovascular disease risk factors (24 loci from 3 studies in EUR) Cardiovascular disease risk factors (Middelberg RP, 2011, 19 SNPs, EUR) Cardiovascular disease risk factors (Schurks M, 2011, 5 SNPs, EUR) Cardiovascular disease risk factors (Smith EN, 2010, 6 SNPs, EUR) Carotenoid and tocopherol levels (Ferrucci L, 2009, 2 SNPs, EUR) Carotid atherosclerosis in HIV infection (Shrestha S, 2010, 7 SNPs, EUR) Carotid intima media thickness (Bis JC, 2011, 11 SNPs, EUR) Cataracts in type 2 diabetes (Lin HJ, 2012, 2 SNPs, ASN) Caudate nucleus volume (Stein JL, 2011, 2 SNPs, EUR) CD4:CD8 lymphocyte ratio (Ferreira MA, 2009, 2 SNPs, EUR) Celiac disease (39 loci from 2 studies in EUR) Celiac disease (Dubois PC, 2010, 40 SNPs, EUR) Celiac disease (Hunt KA, 2008, 8 SNPs, EUR) Celiac disease (van Heel DA, 2007, 2 SNPs, EUR) Celiac disease and Rheumatoid arthritis (Zhernakova A, 2011, 15 SNPs, EUR) Central corneal thickness (8 loci from 3 studies in EUR) Central corneal thickness (Gao X, 2013, 2 SNPs, AMR) Central corneal thickness (Hoehn R, 2012, 2 SNPs, EUR) Central corneal thickness (Lu Y, 2010, 2 SNPs, EUR) Central corneal thickness (Vitart V, 2010, 5 SNPs, EUR) Cervical cancer (Chen D, 2013, 6 SNPs, EUR) Chemerin levels (Bozaoglu K, 2010, 7 SNPs, AMR) Cholelithiasis-related traits in sickle cell anemia (Milton JN, 2012, 1 SNP, AFR) Cholesterol (Igl W, 2010, 1 SNP, EUR) Cholesterol and Triglycerides (Surakka I, 2012, 1 SNP, EUR) Cholesterol, total (60 loci from 2 studies in EUR) Cholesterol, total (Aulchenko YS, 2008, 15 SNPs, EUR) Cholesterol, total (Teslovich TM, 2010, 52 SNPs, EUR) Chronic Hepatitis C infection (3 loci from 2 studies in EUR) Chronic Hepatitis C infection (Duggal P, 2013, 2 SNPs) Chronic Hepatitis C infection (Fellay J, 2010, 2 SNPs, EUR) Chronic Hepatitis C infection (Miki D, 2011, 1 SNP, ASN) Chronic Hepatitis C infection (Rauch A, 2010, 1 SNP, EUR) Chronic kidney disease (29 loci from 2 studies in EUR) Chronic kidney disease (Kottgen A, 2010, 28 SNPs, EUR) Chronic kidney disease (Pattaro C, 2012, 2 SNPs, EUR) Chronic kidney disease and serum creatinine levels (Gudbjartsson DF, 2010, 4 SNPs, EUR) Chronic lymphocytic leukemia (17 loci from 4 studies in EUR) Chronic lymphocytic leukemia (Crowther-Swanepoel D, 2010, 7 SNPs, EUR) Chronic lymphocytic leukemia (Di Bernardo MC, 2008, 6 SNPs, EUR) Chronic lymphocytic leukemia (Slager SL, 2010, 4 SNPs, EUR) Chronic lymphocytic leukemia (Slager SL, 2012, 8 SNPs, EUR) Chronic myeloid leukemia (Kim DH, 2011, 2 SNPs, ASN) Chronic obstructive pulmonary disease (14 loci from 4 studies in EUR) Chronic obstructive pulmonary disease (Cho MH, 2010, 3 SNPs, EUR) Chronic obstructive pulmonary disease (Cho MH, 2011, 4 SNPs, EUR) Chronic obstructive pulmonary disease (Pillai SG, 2009, 2 SNPs, EUR) Chronic obstructive pulmonary disease (Siedlinski M, 2011, 11 SNPs, EUR) Chronic obstructive pulmonary disease-related biomarkers (Kim DK, 2012, 34 SNPs, EUR) Circulating cell-free DNA (Jylhava J, 2012, 1 SNP, EUR) Circulating myeloperoxidase levels (plasma) (Reiner AP, 2013, 3 SNPs, EUR) Circulating myeloperoxidase levels (serum) (Reiner AP, 2013, 5 SNPs, EUR) Circulating vasoactive peptide levels (Verweij N, 2013, 7 SNPs, EUR) Cleft lip (Beaty TH, 2010, 2 SNPs) Coagulation factor levels (5 loci from 2 studies in EUR) Coagulation factor levels (Desch KC, 2012, 7 SNPs, EUR) Coagulation factor levels (Smith NL, 2010, 2 SNPs, EUR) Coffee consumption (6 loci from 2 studies in EUR) Coffee consumption (Amin N, 2011, 4 SNPs, EUR) Coffee consumption (Sulem P, 2011, 2 SNPs, EUR) Cognitive decline (2 loci from 2 studies in EUR) Cognitive decline (Davies G, 2012, 1 SNP, EUR) Cognitive decline (De Jager PL, 2011, 1 SNP, EUR) Cognitive function (LeBlanc M, 2011, 2 SNPs, EUR) Cognitive performance (109 loci from 2 studies in EUR) Cognitive performance (Cirulli ET, 2010, 62 SNPs, EUR) Cognitive performance (Need AC, 2009, 59 SNPs, EUR) Cognitive test performance (Seshadri S, 2007, 14 SNPs, EUR) Colorectal cancer (39 loci from 10 studies in EUR) Colorectal cancer (6 loci from 2 studies in ASN) Colorectal cancer (Broderick P, 2007, 1 SNP, EUR) Colorectal cancer (Cui R, 2011, 2 SNPs, ASN) Colorectal cancer (Dunlop MG, 2012, 3 SNPs, EUR) Colorectal cancer (Fernandez-Rozadilla C, 2013, 3 SNPs, EUR) Colorectal cancer (Houlston RS, 2008, 4 SNPs, EUR) Colorectal cancer (Houlston RS, 2010, 5 SNPs, EUR) Colorectal cancer (Jia WH, 2012, 7 SNPs, ASN) Colorectal cancer (Jiao S, 2012, 7 SNPs, EUR) Colorectal cancer (Peters U, 2011, 5 SNPs, EUR) Colorectal cancer (Peters U, 2012, 15 SNPs, EUR) Colorectal cancer (Tenesa A, 2008, 3 SNPs, EUR) Colorectal cancer (Tomlinson I, 2007, 1 SNP, EUR) Colorectal cancer (Tomlinson IP, 2008, 5 SNPs, EUR) Colorectal cancer (Zanke BW, 2007, 1 SNP, EUR) Common traits (Other) (Eriksson N, 2010, 16 SNPs, EUR) Complement C3 and C4 levels (Yang X, 2012, 10 SNPs, ASN) Comprehensive strength and appendicular lean mass (Han Y, 2012, 2 SNPs, ASN) Conduct disorder (case status) (Dick DM, 2010, 12 SNPs) Conduct disorder (interaction) (Sonuga-Barke EJ, 2008, 15 SNPs, EUR) Conduct disorder (symptom count) (Dick DM, 2010, 14 SNPs) Congenital heart disease (Cordell HJ, 2013, 2 SNPs, EUR) Congenital heart malformation (Hu Z, 2013, 2 SNPs, ASN) Corneal astigmatism (Fan Q, 2011, 6 SNPs, ASN) Corneal astigmatism (Lopes MC, 2013, 17 SNPs, EUR) Corneal curvature (11 loci from 2 studies in EUR) Corneal curvature (Guggenheim JA, 2013, 1 SNP, EUR) Corneal curvature (Han S, 2011, 2 SNPs, ASN) Corneal curvature (Mishra A, 2012, 10 SNPs, EUR) Corneal structure (31 loci from 2 studies in EUR) Corneal structure (Li X, 2011, 5 SNPs, EUR) Corneal structure (Lu Y, 2013, 26 SNPs, EUR) Coronary arterial lesions in patients with Kawasaki disease (Kim JJ, 2013, 1 SNP, ASN) Coronary artery calcification (7 loci from 3 studies in EUR) Coronary artery calcification (O'Donnell CJ, 2007, 3 SNPs, EUR) Coronary artery calcification (O'Donnell CJ, 2011, 3 SNPs, EUR) Coronary artery calcification (van Setten J, 2013, 2 SNPs, EUR) Coronary heart disease (11 loci from 3 studies in ASN) Coronary heart disease (48 loci from 9 studies in EUR) Coronary heart disease (Davies RW, 2012, 5 SNPs, EUR) Coronary heart disease (Erdmann J, 2009, 2 SNPs, EUR) Coronary heart disease (Erdmann J, 2010, 1 SNP, EUR) Coronary heart disease (Hager J, 2012, 3 SNPs, EUR) Coronary heart disease (Lee JY, 2013, 5 SNPs, ASN) Coronary heart disease (Lettre G, 2011, 44 SNPs, AFR) Coronary heart disease (Lu X, 2012, 8 SNPs, ASN) Coronary heart disease (Mehta NN, 2011, 2 SNPs) Coronary heart disease (Reilly MP, 2011, 2 SNPs, EUR) Coronary heart disease (Samani NJ, 2007, 7 SNPs, EUR) Coronary heart disease (Schunkert H, 2011, 30 SNPs, EUR) Coronary heart disease (Slavin TP, 2011, 5 SNPs, EUR) Coronary heart disease (Takeuchi F, 2011, 3 SNPs, ASN) Coronary heart disease (The Coronary Artery Disease (C4D) Genetics Consortium, 2011, 19 SNPs) Coronary heart disease (Tregouet DA, 2009, 2 SNPs, EUR) Coronary heart disease (Wild PS, 2011, 5 SNPs, EUR) Coronary heart disease (WTCCC, 2007, 4 SNPs, EUR) Coronary restenosis (Sampietro ML, 2011, 1 SNP, EUR) Coronary spasm (Suzuki S, 2007, 1 SNP, ASN) Cortical structure (Bakken TE, 2012, 1 SNP, EUR) Cortical thickness (3 loci from 2 studies in EUR) Cortical thickness (Bakken TE, 2011, 1 SNP, EUR) Cortical thickness (Zheng HF, 2012, 2 SNPs, EUR) Creatinine levels (Chambers JC, 2010, 5 SNPs, EUR) Creutzfeldt-Jakob disease (Mead S, 2008, 2 SNPs, EUR) Creutzfeldt-Jakob disease (variant) (Sanchez-Juan P, 2011, 6 SNPs, EUR) Crohn's disease (127 loci from 10 studies in EUR) Crohn's disease (Barrett JC, 2008, 30 SNPs, EUR) Crohn's disease (Franke A, 2007, 3 SNPs, EUR) Crohn's disease (Franke A, 2010, 71 SNPs, EUR) Crohn's disease (Huang J, 2012, 1 SNP, EUR) Crohn's disease (Jostins L, 2012, 30 SNPs, EUR) Crohn's disease (Julia A, 2012, 10 SNPs, EUR) Crohn's disease (Kenny EE, 2012, 17 SNPs, EUR) Crohn's disease (Libioulle C, 2007, 3 SNPs, EUR) Crohn's disease (McGovern DP, 2010, 7 SNPs, EUR) Crohn's disease (need for surgery) (Dubinsky MC, 2013, 2 SNPs, EUR) Crohn's disease (Parkes M, 2007, 9 SNPs, EUR) Crohn's disease (Raelson JV, 2007, 3 SNPs, EUR) Crohn's disease (Rioux JD, 2007, 4 SNPs, EUR) Crohn's disease (time to surgery) (Dubinsky MC, 2013, 1 SNP, EUR) Crohn's disease (WTCCC, 2007, 13 SNPs, EUR) Crohn's disease (Yamazaki K, 2012, 11 SNPs, ASN) Crohn's disease and celiac disease (Festen EA, 2011, 2 SNPs, EUR) Crohn's disease and psoriasis (Ellinghaus D, 2012, 4 SNPs, EUR) Crohn's disease and sarcoidosis (combined) (Franke A, 2008, 1 SNP, EUR) Cutaneous nevi (5 loci from 2 studies in EUR) Cutaneous nevi (Falchi M, 2009, 2 SNPs, EUR) Cutaneous nevi (Nan H, 2011, 3 SNPs, EUR) Cystatin C (Hwang SJ, 2007, 1 SNP, EUR) Cystic fibrosis severity (Wright FA, 2011, 6 SNPs, EUR) Cystic fibrosis-related diabetes (Blackman SM, 2013, 1 SNP) Cytomegalovirus antibody response (Kuparinen T, 2011, 9 SNPs, EUR) D-dimer levels (Smith NL, 2011, 15 SNPs, EUR) Dehydroepiandrosterone sulphate levels (Zhai G, 2011, 8 SNPs, EUR) Dengue shock syndrome (Khor CC, 2011, 4 SNPs, ASN) Dental caries (61 loci from 3 studies in EUR) Dental caries (Shaffer JR, 2011, 3 SNPs, EUR) Dental caries (Shaffer JR, 2012, 32 SNPs, EUR) Dental caries (Wang X, 2012, 34 SNPs, EUR) Depression (quantitative trait) (12 loci from 2 studies in EUR) Depression (quantitative trait) (Hek K, 2013, 2 SNPs, EUR) Depression (quantitative trait) (Terracciano A, 2010, 11 SNPs, EUR) Depression and alcohol dependence (Edwards AC, 2011, 8 SNPs, EUR) Diabetes (gestational) (Kwak SH, 2012, 3 SNPs, ASN) Diabetes (incident) (Meigs JB, 2007, 1 SNP, EUR) Diabetes related insulin traits (Meigs JB, 2007, 4 SNPs, EUR) Diabetic retinopathy (8 loci from 2 studies in ASN) Diabetic retinopathy (Grassi MA, 2011, 19 SNPs, EUR) Diabetic retinopathy (Huang YC, 2011, 8 SNPs, ASN) Diabetic retinopathy (Sheu WH, 2013, 1 SNP, ASN) Dialysis-related mortality (Murea M, 2011, 26 SNPs, AFR) Diastolic blood pressure (27 loci from 3 studies in EUR) Diastolic blood pressure (Ehret GB, 2011, 19 SNPs, EUR) Diastolic blood pressure (Levy D, 2009, 7 SNPs, EUR) Diastolic blood pressure (Newton-Cheh C, 2009, 6 SNPs, EUR) Dietary macronutrient intake (8 loci from 2 studies in EUR) Dietary macronutrient intake (Chu AY, 2013, 3 SNPs, EUR) Dietary macronutrient intake (Tanaka T, 2013, 7 SNPs, EUR) Digit length ratio (2 loci from 2 studies in EUR) Digit length ratio (Lawrance-Owen AJ, 2012, 1 SNP, EUR) Digit length ratio (Medland SE, 2010, 1 SNP, EUR) Dilated cardiomyopathy (Villard E, 2011, 2 SNPs, EUR) Disc degeneration (lumbar) (Williams FM, 2012, 35 SNPs, EUR) DNA methylation (parent-of-origin) (Renteria ME, 2013, 7 SNPs, EUR) DNA methylation (variation) (Renteria ME, 2013, 19 SNPs, EUR) Drinking behavior (Takeuchi F, 2011, 2 SNPs, ASN) Drinking behavior (Yang X, 2013, 1 SNP, ASN) Drug-induced liver injury (Urban TJ, 2012, 1 SNP, EUR) Drug-induced liver injury (amoxicillin-clavulanate) (Lucena MI, 2011, 2 SNPs, EUR) Drug-induced liver injury (flucloxacillin) (Daly AK, 2009, 6 SNPs, EUR) Duodenal ulcer (Tanikawa C, 2012, 2 SNPs, ASN) Dupuytren's disease (13 loci from 2 studies in EUR) Dupuytren's disease (Dolmans GH, 2011, 12 SNPs, EUR) Dupuytren's disease (Ojwang JO, 2010, 1 SNP, EUR) E-selectin levels (Qi L, 2010, 1 SNP, EUR) Eating disorders (15 loci from 2 studies in EUR) Eating disorders (Boraska V, 2012, 7 SNPs, EUR) Eating disorders (purging via substances) (Wade TD, 2013, 11 SNPs, EUR) Eating disorders (Wade TD, 2013, 8 SNPs, EUR) Echocardiographic traits (Vasan RS, 2007, 8 SNPs, EUR) Economic and political preferences (Benjamin DJ, 2012, 17 SNPs, EUR) Economic and political preferences (environmentalism) (Benjamin DJ, 2012, 17 SNPs, EUR) Economic and political preferences (fairness) (Benjamin DJ, 2012, 7 SNPs, EUR) Economic and political preferences (feminism/equality) (Benjamin DJ, 2012, 12 SNPs, EUR) Economic and political preferences (immigration/crime) (Benjamin DJ, 2012, 15 SNPs, EUR) Economic and political preferences (time) (Benjamin DJ, 2012, 10 SNPs, EUR) Educational attainment (Rietveld CA, 2013, 13 SNPs, EUR) Electrocardiographic conduction measures (Ritchie MD, 2013, 5 SNPs, EUR) Electrocardiographic conduction measures (Smith JG, 2009, 7 SNPs) Electrocardiographic traits (17 loci from 2 studies in EUR) Electrocardiographic traits (Chambers JC, 2010, 3 SNPs) Electrocardiographic traits (Holm H, 2010, 18 SNPs, EUR) Electrocardiographic traits (Newton-Cheh C, 2007, 2 SNPs, EUR) Electroencephalographic traits in alcoholism (Kang SJ, 2012, 8 SNPs, EUR) Emphysema-related traits (Kong X, 2010, 7 SNPs, EUR) End-stage coagulation (Williams FM, 2013, 23 SNPs, EUR) End-stage renal disease (Hanson RL, 2007, 1 SNP, AMR) End-stage renal disease (non-diabetic) (Bostrom MA, 2010, 1 SNP, AFR) Endometrial cancer (Spurdle AB, 2011, 2 SNPs, EUR) Endometriosis (21 loci from 3 studies in EUR) Endometriosis (3 loci from 2 studies in ASN) Endometriosis (Adachi S, 2010, 2 SNPs, ASN) Endometriosis (Albertsen HM, 2013, 15 SNPs, EUR) Endometriosis (Nyholt DR, 2012, 7 SNPs, EUR) Endometriosis (Painter JN, 2010, 3 SNPs, EUR) Endometriosis (Uno S, 2010, 2 SNPs, ASN) Endothelial function traits (Vasan RS, 2007, 1 SNP, EUR) Entorhinal cortical thickness (Furney SJ, 2010, 6 SNPs, EUR) Eosinophil counts (Gudbjartsson DF, 2009, 7 SNPs, EUR) Eosinophilic esophagitis (pediatric) (Rothenberg ME, 2010, 14 SNPs, EUR) Epilepsy (generalized) (EPICURE Consortium, 2012, 10 SNPs, EUR) Epilepsy (Guo Y, 2011, 1 SNP, ASN) Epirubicin-induced leukopenia (Srinivasan Y, 2011, 2 SNPs, ASN) Epstein-Barr virus immune response (EBNA-1) (Rubicz R, 2013, 2 SNPs, AMR) Erectile dysfunction (Hotaling JM, 2012, 6 SNPs, EUR) Erectile dysfunction and prostate cancer treatment (Kerns SL, 2010, 23 SNPs, AFR) Erythrocyte sedimentation rate (Kullo IJ, 2011, 5 SNPs, EUR) Esophageal cancer (alcohol interaction) (Wu C, 2012, 4 SNPs, ASN) Esophageal cancer (8 loci from 2 studies in ASN) Esophageal cancer (Cui R, 2009, 2 SNPs, ASN) Esophageal cancer (squamous cell) (Wu C, 2012, 7 SNPs, ASN) Esophageal cancer (Wu C, 2011, 11 SNPs, ASN) Esophageal cancer and gastric cancer (Abnet CC, 2010, 4 SNPs, ASN) Esophageal squamous cell cancer (length of survival) (Wu C, 2013, 1 SNP, ASN) Essential tremor (2 loci from 2 studies in EUR) Essential tremor (Stefansson H, 2009, 1 SNP, EUR) Essential tremor (Thier S, 2012, 1 SNP, EUR) Estradiol levels (Prescott J, 2012, 8 SNPs, EUR) Estradiol plasma levels (breast cancer) (Liu M, 2013, 18 SNPs, EUR) Event-related brain oscillations (Zlojutro M, 2010, 3 SNPs) Ewing sarcoma (Postel-Vinay S, 2012, 3 SNPs, EUR) Exercise (leisure time) (De Moor MH, 2009, 3 SNPs, EUR) Exercise treadmill test traits (Vasan RS, 2007, 4 SNPs, EUR) Eye color (13 loci from 3 studies in EUR) Eye color (Candille SI, 2012, 3 SNPs, EUR) Eye color (Eriksson N, 2010, 8 SNPs, EUR) Eye color (Zhang M, 2013, 8 SNPs, EUR) Eye color traits (Liu F, 2010, 3 SNPs, EUR) F-cell distribution (Bhatnagar P, 2011, 11 SNPs, AFR) F-cell distribution (Menzel S, 2007, 3 SNPs, EUR) Facial morphology (Paternoster L, 2012, 1 SNP, EUR) Factor VII (Yang Q, 2007, 4 SNPs, EUR) Fasting glucose-related traits (Dupuis J, 2010, 30 SNPs, EUR) Fasting glucose-related traits (interaction with BMI) (Manning AK, 2012, 31 SNPs, EUR) Fasting insulin-related traits (Dupuis J, 2010, 4 SNPs, EUR) Fasting insulin-related traits (interaction with BMI) (Manning AK, 2012, 20 SNPs, EUR) Fasting plasma glucose (10 loci from 5 studies in EUR) Fasting plasma glucose (Bouatia-Naji N, 2008, 1 SNP, EUR) Fasting plasma glucose (Bouatia-Naji N, 2008, 1 SNP, EUR) Fasting plasma glucose (Chambers JC, 2009, 1 SNP) Fasting plasma glucose (Chen WM, 2008, 1 SNP, EUR) Fasting plasma glucose (Meigs JB, 2007, 6 SNPs, EUR) Fasting plasma glucose (Prokopenko I, 2008, 3 SNPs, EUR) Fasting plasma glucose (Rasmussen-Torvik LJ, 2012, 3 SNPs, EUR) Fasting plasma glucose (Xing C, 2010, 1 SNP, EUR) Fat distribution (HIV) (Irvin MR, 2011, 17 SNPs, EUR) Femoral neck bone geometry (Sun L, 2011, 2 SNPs, ASN) Femoral neck bone geometry and menarche (age at onset) (Ran S, 2013, 6 SNPs, EUR) Fetal hemoglobin levels (Solovieff N, 2009, 3 SNPs, AFR) Fetal hemoglobin levels (Uda M, 2008, 2 SNPs, EUR) Fibrinogen (8 loci from 3 studies in EUR) Fibrinogen (Danik JS, 2009, 6 SNPs, EUR) Fibrinogen (Dehghan A, 2009, 4 SNPs, EUR) Fibrinogen (Lovely RS, 2011, 5 SNPs, EUR) Folate pathway vitamin levels (11 loci from 2 studies in EUR) Folate pathway vitamin levels (Hazra A, 2009, 9 SNPs, EUR) Folate pathway vitamin levels (Tanaka T, 2009, 5 SNPs, EUR) Follicular lymphoma (4 loci from 3 studies in EUR) Follicular lymphoma (Conde L, 2010, 3 SNPs, EUR) Follicular lymphoma (Skibola CF, 2009, 1 SNP, EUR) Follicular lymphoma (Smedby KE, 2011, 1 SNP, EUR) Formal thought disorder in schizophrenia (Wang KS, 2012, 5 SNPs, EUR) Freckles (Sulem P, 2007, 3 SNPs, EUR) Freckles (Sulem P, 2008, 1 SNP, EUR) Freckling (Eriksson N, 2010, 4 SNPs, EUR) Fuchs's corneal dystrophy (Baratz KH, 2010, 2 SNPs, EUR) Functional MRI (Liu X, 2010, 2 SNPs) Gallbladder cancer (Cha PC, 2012, 5 SNPs, ASN) Gallstones (Buch S, 2007, 1 SNP, EUR) Gambling (Lind PA, 2012, 5 SNPs, EUR) Gamma gluatamyl transferase levels (Middelberg RP, 2011, 4 SNPs, EUR) Gamma glutamyl transpeptidase (Kim YJ, 2011, 7 SNPs, ASN) Gastric cancer (Shi Y, 2011, 2 SNPs, ASN) Gaucher disease severity (Zhang CK, 2012, 3 SNPs, EUR) Glaucoma (3 loci from 2 studies in ASN) Glaucoma (Burdon KP, 2011, 2 SNPs, EUR) Glaucoma (exfoliation) (Thorleifsson G, 2007, 1 SNP, EUR) Glaucoma (Meguro A, 2010, 2 SNPs, ASN) Glaucoma (primary open-angle) (4 loci from 2 studies in EUR) Glaucoma (primary open-angle) (8 loci from 2 studies in ASN) Glaucoma (primary open-angle) (Nakano M, 2012, 1 SNP, ASN) Glaucoma (primary open-angle) (Osman W, 2012, 3 SNPs, ASN) Glaucoma (primary open-angle) (Thorleifsson G, 2010, 1 SNP, EUR) Glaucoma (primary open-angle) (Vithana EN, 2012, 5 SNPs, ASN) Glaucoma (primary open-angle) (Wiggs JL, 2012, 4 SNPs, EUR) Glaucoma (Takamoto M, 2012, 1 SNP, ASN) Glioblastoma (Xiao Y, 2012, 1 SNP, EUR) Glioma (9 loci from 2 studies in EUR) Glioma (high-grade) (Wrensch M, 2009, 3 SNPs, EUR) Glioma (Rajaraman P, 2012, 3 SNPs, EUR) Glioma (Sanson M, 2011, 7 SNPs, EUR) Glioma (Shete S, 2009, 7 SNPs, EUR) Glioma (Yang TH, 2011, 1 SNP, EUR) Glomerular filtration rate (Tin A, 2013, 6 SNPs, EUR) Glomerulosclerosis (Genovese G, 2010, 1 SNP) Glycated hemoglobin levels (15 loci from 3 studies in EUR) Glycated hemoglobin levels (Franklin CS, 2010, 1 SNP, EUR) Glycated hemoglobin levels (Pare G, 2008, 4 SNPs, EUR) Glycated hemoglobin levels (Ryu J, 2012, 1 SNP, ASN) Glycated hemoglobin levels (Soranzo N, 2010, 11 SNPs, EUR) Glycemic traits (Go MJ, 2013, 11 SNPs, ASN) Gout (Kottgen A, 2012, 6 SNPs, EUR) Graves' disease (22 loci from 3 studies in ASN) Graves' disease (Chu X, 2011, 11 SNPs, ASN) Graves' disease (Nakabayashi K, 2011, 7 SNPs, ASN) Graves' disease (Zhao SX, 2013, 6 SNPs, ASN) Hair color (12 loci from 2 studies in EUR) Hair color (Eriksson N, 2010, 12 SNPs, EUR) Hair color (Kenny EE, 2012, 1 SNP) Hair color (Zhang M, 2013, 6 SNPs, EUR) Hair morphology (Medland SE, 2009, 15 SNPs, EUR) Handedness in dyslexia (Scerri TS, 2010, 1 SNP, EUR) Haptoglobin levels (Froguel P, 2012, 1 SNP, EUR) HbA2 levels (Menzel S, 2012, 2 SNPs, EUR) HDL cholesterol (65 loci from 8 studies in EUR) HDL cholesterol (7 loci from 2 studies in ASN) HDL cholesterol (Aulchenko YS, 2008, 10 SNPs, EUR) HDL cholesterol (Coram MA, 2013, 9 SNPs) HDL cholesterol (Heid IM, 2008, 3 SNPs, EUR) HDL cholesterol (Hiura Y, 2009, 1 SNP, ASN) HDL cholesterol (Kathiresan S, 2008, 14 SNPs, EUR) HDL cholesterol (Kathiresan S, 2008, 6 SNPs, EUR) HDL cholesterol (Kim YJ, 2011, 9 SNPs, ASN) HDL cholesterol (Ridker PM, 2009, 1 SNP, EUR) HDL cholesterol (Sabatti C, 2008, 5 SNPs, EUR) HDL cholesterol (Teslovich TM, 2010, 47 SNPs, EUR) HDL cholesterol (Waterworth DM, 2010, 12 SNPs, EUR) HDL cholesterol (Weissglas-Volkov D, 2013, 5 SNPs, AMR) HDL cholesterol (Willer CJ, 2008, 10 SNPs, EUR) HDL Cholesterol - Triglycerides (HDLC-TG) (Kraja AT, 2011, 8 SNPs, EUR) Head circumference (infant) (Taal HR, 2012, 3 SNPs, EUR) Hearing impairment (Van Laer L, 2010, 2 SNPs, EUR) Heart failure (17 loci from 2 studies in EUR) Heart failure (Larson MG, 2007, 1 SNP, EUR) Heart failure (Smith NL, 2010, 16 SNPs, EUR) Heart rate (den Hoed M, 2013, 32 SNPs, EUR) Heart rate (Jeff JM, 2013, 5 SNPs, AFR) Heart rate variability traits (4 loci from 2 studies in EUR) Heart rate variability traits (Newton-Cheh C, 2007, 2 SNPs, EUR) Heart rate variability traits (Rankinen T, 2011, 2 SNPs, EUR) Height (285 loci from 10 studies in EUR) Height (33 loci from 2 studies in AFR) Height (57 loci from 7 studies in ASN) Height (Berndt SI, 2013, 86 SNPs, EUR) Height (Carty CL, 2011, 8 SNPs, AFR) Height (Cho YS, 2009, 5 SNPs, ASN) Height (Croteau-Chonka DC, 2010, 7 SNPs, ASN) Height (Estrada K, 2009, 5 SNPs, EUR) Height (Gudbjartsson DF, 2008, 52 SNPs, EUR) Height (Hao Y, 2013, 11 SNPs, ASN) Height (Johansson A, 2008, 1 SNP, EUR) Height (Kim HN, 2010, 1 SNP, ASN) Height (Kim JJ, 2009, 15 SNPs, ASN) Height (Lango Allen H, 2010, 199 SNPs, EUR) Height (Lei SF, 2008, 1 SNP, ASN) Height (Lettre G, 2008, 18 SNPs, EUR) Height (Liu JZ, 2010, 8 SNPs, EUR) Height (N'Diaye A, 2011, 33 SNPs, AFR) Height (Okada Y, 2010, 25 SNPs, ASN) Height (Sanna S, 2008, 5 SNPs, EUR) Height (Soranzo N, 2009, 20 SNPs, EUR) Height (Tonjes A, 2009, 1 SNP, EUR) Height (Weedon MN, 2007, 1 SNP, EUR) Height (Weedon MN, 2008, 20 SNPs, EUR) Helicobacter pylori serologic status (Mayerle J, 2013, 2 SNPs, EUR) Hematocrit (Ganesh SK, 2009, 8 SNPs, EUR) Hematological and biochemical traits (Kamatani Y, 2010, 29 SNPs, ASN) Hematological parameters (Soranzo N, 2009, 12 SNPs, EUR) Hematology traits (Ferreira MA, 2009, 6 SNPs, EUR) Hematology traits (Hong KW, 2013, 5 SNPs, ASN) Hematology traits (Li J, 2012, 12 SNPs) Hemoglobin (Chambers JC, 2009, 2 SNPs) Hemoglobin (Ganesh SK, 2009, 7 SNPs, EUR) Hemostatic factors and hematological phenotypes (24 loci from 2 studies in EUR) Hemostatic factors and hematological phenotypes (Oudot-Mellakh T, 2012, 9 SNPs, EUR) Hemostatic factors and hematological phenotypes (Yang Q, 2007, 18 SNPs, EUR) Hepatitis B (5 loci from 2 studies in ASN) Hepatitis B (Kamatani Y, 2009, 1 SNP, ASN) Hepatitis B (Liu L, 2011, 1 SNP, ASN) Hepatitis B (Mbarek H, 2011, 4 SNPs, ASN) Hepatitis B (viral clearance) (Nishida N, 2012, 4 SNPs, ASN) Hepatitis B vaccine response (Png E, 2011, 3 SNPs) Hepatitis C induced liver cirrhosis (Urabe Y, 2013, 5 SNPs, ASN) Hepatitis C induced liver fibrosis (Patin E, 2012, 6 SNPs, EUR) Hepatocellular carcinoma (8 loci from 4 studies in ASN) Hepatocellular carcinoma (Clifford RJ, 2010, 3 SNPs, ASN) Hepatocellular carcinoma (hepatitis B virus related) (Jiang DK, 2012, 2 SNPs, ASN) Hepatocellular carcinoma (Kumar V, 2011, 2 SNPs, ASN) Hepatocellular carcinoma (Li S, 2012, 3 SNPs, ASN) Hepatocellular carcinoma (Zhang H, 2010, 1 SNP, ASN) Hepcidin levels (Traglia M, 2011, 8 SNPs) Hip bone size (Liu YZ, 2008, 1 SNP, EUR) Hip geometry (Kiel DP, 2007, 16 SNPs, EUR) Hippocampal atrophy (30 loci from 2 studies in EUR) Hippocampal atrophy (Melville SA, 2012, 12 SNPs, EUR) Hippocampal atrophy (Potkin SG, 2009, 21 SNPs, EUR) Hippocampal volume (Bis JC, 2012, 5 SNPs, EUR) Hirschsprung's disease (Garcia-Barcelo MM, 2009, 2 SNPs, ASN) HIV-1 control (Fellay J, 2009, 42 SNPs, EUR) HIV-1 control (Pelak K, 2010, 10 SNPs, AFR) HIV-1 control (Pereyra F, 2010, 8 SNPs) HIV-1 progression (Herbeck JT, 2010, 1 SNP, EUR) HIV-1 replication (Bol SM, 2011, 1 SNP, EUR) HIV-1 susceptibility (14 loci from 2 studies in AFR) HIV-1 susceptibility (Lingappa JR, 2011, 9 SNPs, AFR) HIV-1 susceptibility (Petrovski S, 2010, 6 SNPs, AFR) HIV-1 viral setpoint (Lingappa JR, 2011, 14 SNPs, AFR) HIV-associated dementia (Levine AJ, 2012, 4 SNPs, EUR) Hoarding (Perroud N, 2010, 3 SNPs, EUR) Hodgkin's lymphoma (9 loci from 2 studies in EUR) Hodgkin's lymphoma (Enciso-Mora V, 2010, 5 SNPs, EUR) Hodgkin's lymphoma (Urayama KY, 2012, 4 SNPs, EUR) Homocysteine levels (Lange LA, 2010, 1 SNP, ASN) Homocysteine levels (Pare G, 2009, 2 SNPs, EUR) HPV seropositivity (Chen D, 2011, 1 SNP, EUR) Hyperactive-impulsive symptoms (Lasky-Su J, 2008, 14 SNPs, EUR) Hypersomnia (HLA-DQB1*06:02 negative) (Khor SS, 2013, 5 SNPs, ASN) Hypertension (18 loci from 5 studies in EUR) Hypertension (Adeyemo A, 2009, 2 SNPs, AFR) Hypertension (Ehret GB, 2011, 11 SNPs, EUR) Hypertension (Guo Y, 2012, 3 SNPs, ASN) Hypertension (Levy D, 2009, 4 SNPs, EUR) Hypertension (Org E, 2009, 1 SNP, EUR) Hypertension (Padmanabhan S, 2010, 1 SNP, EUR) Hypertension (Slavin TP, 2011, 9 SNPs, EUR) Hypertension (WTCCC, 2007, 2 SNPs, EUR) Hypertension (young onset) (Yang HC, 2009, 1 SNP, ASN) Hypertension risk in short sleep duration (Kim SJ, 2012, 3 SNPs, ASN) Hypertriglyceridemia (Johansen CT, 2010, 5 SNPs, EUR) Hypertriglyceridemia (Weissglas-Volkov D, 2013, 9 SNPs, AMR) Hypospadias (van der Zanden LF, 2010, 1 SNP, EUR) Hypothyroidism (Denny JC, 2011, 1 SNP, EUR) Hypothyroidism (Eriksson N, 2012, 19 SNPs, EUR) Idiopathic pulmonary fibrosis (Mushiroda T, 2008, 1 SNP, ASN) IFN-related cytopenia (Thompson AJ, 2011, 1 SNP, EUR) IgA levels (Yang C, 2012, 1 SNP, ASN) IgA nephropathy (Yu XQ, 2011, 9 SNPs, ASN) IgE grass sensitization (Ramasamy A, 2011, 9 SNPs, EUR) IgE levels (11 loci from 2 studies in EUR) IgE levels (Granada M, 2011, 11 SNPs, EUR) IgE levels (Levin AM, 2012, 4 SNPs) IgE levels (Weidinger S, 2008, 2 SNPs, EUR) IgG glycosylation (Lauc G, 2013, 699 SNPs, EUR) IgG levels (Buck D, 2012, 1 SNP, EUR) IgG levels (Liao M, 2012, 1 SNP, ASN) IgM levels (Yang M, 2012, 3 SNPs, ASN) Ileal carcinoids (Walsh KM, 2010, 4 SNPs, EUR) Immune reponse to smallpox (secreted IFN-alpha) (Kennedy RB, 2012, 32 SNPs, EUR) Immune reponse to smallpox (secreted IL-10) (Kennedy RB, 2012, 6 SNPs, EUR) Immune reponse to smallpox (secreted IL-12p40) (Kennedy RB, 2012, 10 SNPs, EUR) Immune reponse to smallpox (secreted IL-1beta) (Kennedy RB, 2012, 13 SNPs, EUR) Immune reponse to smallpox (secreted IL-2) (Kennedy RB, 2012, 17 SNPs, EUR) Immune reponse to smallpox (secreted TNF-alpha) (Kennedy RB, 2012, 6 SNPs, EUR) Immune response to anthrax vaccine (Pajewski NM, 2012, 8 SNPs, EUR) Immune response to smallpox vaccine (IL-6) (Kennedy RB, 2012, 9 SNPs, EUR) Immune response to smallpox vaccine (IL-6) (Ovsyannikova IG, 2012, 37 SNPs, AFR) Immunoglobulin A (Ferreira RC, 2010, 12 SNPs, EUR) Inattentive symptoms (Lasky-Su J, 2008, 15 SNPs, EUR) Infantile hypertrophic pyloric stenosis (Feenstra B, 2012, 5 SNPs, EUR) Inflammatory biomarkers (25 loci from 2 studies in EUR) Inflammatory biomarkers (Aslibekyan S, 2012, 19 SNPs, EUR) Inflammatory biomarkers (Naitza S, 2012, 7 SNPs, EUR) Inflammatory bowel disease (115 loci from 3 studies in EUR) Inflammatory bowel disease (Duerr RH, 2006, 3 SNPs, EUR) Inflammatory bowel disease (early onset) (Imielinski M, 2009, 4 SNPs, EUR) Inflammatory bowel disease (Jostins L, 2012, 110 SNPs, EUR) Inflammatory bowel disease (Kugathasan S, 2008, 6 SNPs, EUR) Inflammatory bowel disease (Okada Y, 2011, 5 SNPs, ASN) Information processing speed (Luciano M, 2010, 25 SNPs, EUR) Insomnia (Byrne EM, 2013, 3 SNPs, EUR) Insomnia (caffeine-induced) (Byrne EM, 2012, 9 SNPs, EUR) Insulin resistance/response (Irvin MR, 2011, 14 SNPs, AFR) Insulin-like growth factors (Kaplan RC, 2011, 8 SNPs, EUR) Insulin-related traits (Chen G, 2012, 6 SNPs, AFR) Intelligence (childhood) (Benyamin B, 2013, 6 SNPs, EUR) Intelligence (Loo SK, 2012, 21 SNPs, EUR) Interleukin-18 levels (He M, 2010, 2 SNPs, EUR) Interstitial lung disease (Fingerlin TE, 2013, 16 SNPs, EUR) Interstitial lung disease (Nyberg F, 2011, 2 SNPs, ASN) Intracranial aneurysm (9 loci from 3 studies in EUR) Intracranial aneurysm (Bilguvar K, 2008, 4 SNPs, EUR) Intracranial aneurysm (Foroud T, 2012, 1 SNP, EUR) Intracranial aneurysm (Low SK, 2012, 4 SNPs, ASN) Intracranial aneurysm (Yasuno K, 2010, 6 SNPs, EUR) Intracranial volume (Ikram MA, 2012, 2 SNPs, EUR) Intraocular pressure (van Koolwijk LM, 2012, 2 SNPs, EUR) Iris characteristics (Larsson M, 2011, 7 SNPs, EUR) Iris color (Kayser M, 2008, 1 SNP, EUR) Iron deficiency (McLaren CE, 2011, 1 SNP, EUR) Iron levels (Pichler I, 2011, 5 SNPs, EUR) Iron levels (Tanaka T, 2009, 1 SNP, EUR) Iron status biomarkers (28 loci from 3 studies in EUR) Iron status biomarkers (Benyamin B, 2008, 27 SNPs, EUR) Iron status biomarkers (Benyamin B, 2009, 4 SNPs, EUR) Iron status biomarkers (McLaren CE, 2011, 9 SNPs, EUR) Iron status biomarkers (Oexle K, 2010, 5 SNPs, EUR) Job-related exhaustion (Sulkava S, 2013, 1 SNP, EUR) Kawasaki disease (13 loci from 3 studies in ASN) Kawasaki disease (6 loci from 3 studies in EUR) Kawasaki disease (Burgner D, 2009, 2 SNPs, EUR) Kawasaki disease (Khor CC, 2011, 2 SNPs, EUR) Kawasaki disease (Kim JJ, 2011, 2 SNPs, ASN) Kawasaki disease (Lee YC, 2012, 6 SNPs, ASN) Kawasaki disease (Onouchi Y, 2012, 5 SNPs, ASN) Kawasaki disease (Tsai FJ, 2011, 2 SNPs, EUR) Keloid (Nakashima M, 2010, 4 SNPs, ASN) Kidney stones (Thorleifsson G, 2009, 1 SNP, EUR) Knee osteoarthritis (Nakajima M, 2010, 1 SNP, ASN) Knee osteoarthritis (Valdes AM, 2008, 2 SNPs, EUR) Large B-cell lymphoma (Kumar V, 2011, 2 SNPs, ASN) LDL (oxidized) (Makela KM, 2012, 1 SNP, EUR) LDL cholesterol (58 loci from 9 studies in EUR) LDL cholesterol (Aulchenko YS, 2008, 12 SNPs, EUR) LDL cholesterol (Burkhardt R, 2008, 2 SNPs, ASN) LDL cholesterol (Coram MA, 2013, 5 SNPs) LDL cholesterol (Kathiresan S, 2008, 11 SNPs, EUR) LDL cholesterol (Kathiresan S, 2008, 7 SNPs, EUR) LDL cholesterol (Rasmussen-Torvik LJ, 2012, 1 SNP, AFR) LDL cholesterol (Sabatti C, 2008, 7 SNPs, EUR) LDL cholesterol (Sandhu MS, 2008, 3 SNPs, EUR) LDL cholesterol (Shen H, 2010, 2 SNPs, EUR) LDL cholesterol (Teslovich TM, 2010, 37 SNPs, EUR) LDL cholesterol (Wallace C, 2008, 3 SNPs, EUR) LDL cholesterol (Waterworth DM, 2010, 11 SNPs, EUR) LDL cholesterol (Willer CJ, 2008, 7 SNPs, EUR) Lean body mass and age at menarche (combined) (Hai R, 2012, 1 SNP, ASN) Left ventricular mass (Arnett DK, 2009, 2 SNPs, EUR) Left ventricular mass (Arnett DK, 2011, 3 SNPs, AFR) Leishmaniasis (visceral) (Donnelly, 2013, 1 SNP) Lentiform nucleus volume (Hibar DP, 2012, 14 SNPs, EUR) Leprosy (9 loci from 2 studies in ASN) Leprosy (Zhang F, 2011, 4 SNPs, ASN) Leprosy (Zhang FR, 2009, 6 SNPs, ASN) Life threatening arrhythmia (Murray SS, 2012, 2 SNPs, EUR) Lipid levels in hepatitis C treatment (Clark PJ, 2012, 1 SNP, EUR) Lipid metabolism phenotypes (32 loci from 2 studies in EUR) Lipid metabolism phenotypes (Chasman DI, 2009, 73 SNPs, EUR) Lipid metabolism phenotypes (Kettunen J, 2012, 18 SNPs, EUR) Lipid traits (Surakka I, 2011, 1 SNP, EUR) Lipoprotein-associated phospholipase A2 activity and mass (14 loci from 3 studies in EUR) Lipoprotein-associated phospholipase A2 activity and mass (Chu AY, 2012, 9 SNPs, EUR) Lipoprotein-associated phospholipase A2 activity and mass (Grallert H, 2011, 7 SNPs, EUR) Lipoprotein-associated phospholipase A2 activity and mass (Suchindran S, 2010, 5 SNPs, EUR) Lipoprotein-associated phospholipase A2 activity change in response to statin therapy (Chu AY, 2012, 7 SNPs, EUR) Liver enzyme levels (alanine transaminase) (Chambers JC, 2011, 4 SNPs, EUR) Liver enzyme levels (alkaline phosphatase) (Chambers JC, 2011, 14 SNPs, EUR) Liver enzyme levels (gamma-glutamyl transferase) (Chambers JC, 2011, 26 SNPs, EUR) Liver enzyme levels (Yuan X, 2008, 11 SNPs, EUR) Longevity (43 loci from 5 studies in EUR) Longevity (Deelen J, 2011, 1 SNP, EUR) Longevity (Malovini A, 2011, 1 SNP, EUR) Longevity (Nebel A, 2011, 1 SNP, EUR) Longevity (Newman AB, 2010, 1 SNP, EUR) Longevity (Yashin AI, 2010, 39 SNPs, EUR) Lp (a) levels (5 loci from 2 studies in EUR) Lp (a) levels (Ober C, 2009, 1 SNP, EUR) Lp (a) levels (Qi Q, 2011, 4 SNPs, EUR) Lumiracoxib-related liver injury (Singer JB, 2010, 1 SNP, EUR) Lung adenocarcinoma (5 loci from 2 studies in ASN) Lung adenocarcinoma (Hsiung CA, 2010, 1 SNP, ASN) Lung adenocarcinoma (Landi MT, 2009, 5 SNPs, EUR) Lung adenocarcinoma (Miki D, 2010, 2 SNPs, ASN) Lung adenocarcinoma (Shiraishi K, 2012, 4 SNPs, ASN) Lung cancer (13 loci from 6 studies in EUR) Lung cancer (8 loci from 2 studies in ASN) Lung cancer (Amos CI, 2008, 3 SNPs, EUR) Lung cancer (Broderick P, 2009, 7 SNPs, EUR) Lung Cancer (DNA repair capacity) (Wang LE, 2012, 2 SNPs, EUR) Lung cancer (Hu Z, 2011, 4 SNPs, ASN) Lung cancer (Hung RJ, 2008, 1 SNP, EUR) Lung cancer (Lan Q, 2012, 7 SNPs, ASN) Lung cancer (Li Y, 2010, 1 SNP, EUR) Lung cancer (Liu P, 2008, 1 SNP, EUR) Lung cancer (McKay JD, 2008, 2 SNPs, EUR) Lung cancer (Timofeeva MN, 2012, 1 SNP, EUR) Lung cancer (Wang Y, 2008, 3 SNPs, EUR) Lung cancer-asbestos exposure interaction (Wei S, 2012, 2 SNPs, EUR) Lymphocyte counts (Cusanovich DA, 2012, 2 SNPs, EUR) Lymphoma (Vijai J, 2013, 13 SNPs, EUR) Magnesium levels (Meyer TE, 2010, 9 SNPs, EUR) Major CVD (Larson MG, 2007, 1 SNP, EUR) Major depressive disorder (75 loci from 9 studies in EUR) Major depressive disorder (Aragam N, 2011, 5 SNPs, EUR) Major depressive disorder (broad) (Shyn SI, 2009, 9 SNPs, EUR) Major depressive disorder (GENDEP Investigators, 2013, 49 SNPs, EUR) Major depressive disorder (Kohli MA, 2011, 1 SNP, EUR) Major depressive disorder (Lewis CM, 2010, 4 SNPs, EUR) Major depressive disorder (Muglia P, 2008, 1 SNP, EUR) Major depressive disorder (Rietschel M, 2010, 3 SNPs, EUR) Major depressive disorder (Shi J, 2010, 9 SNPs, EUR) Major depressive disorder (Sullivan, 2012, 5 SNPs, EUR) Major depressive disorder (Wray NR, 2010, 4 SNPs, EUR) Major mood disorders (McMahon FJ, 2010, 1 SNP, EUR) Malaria (11 loci from 3 studies in AFR) Malaria (Band G, 2013, 6 SNPs, AFR) Malaria (Jallow M, 2009, 3 SNPs, AFR) Malaria (Timmann C, 2012, 4 SNPs, AFR) Male infertility (Aston KI, 2009, 5 SNPs, EUR) Male-pattern baldness (8 loci from 2 studies in EUR) Male-pattern baldness (Brockschmidt FF, 2011, 2 SNPs, EUR) Male-pattern baldness (Hillmer AM, 2008, 1 SNP, EUR) Male-pattern baldness (Li R, 2012, 8 SNPs, EUR) Male-pattern baldness (Richards JB, 2008, 2 SNPs, EUR) Mammographic density (2 loci from 2 studies in EUR) Mammographic density (Lindstrom S, 2011, 1 SNP, EUR) Mammographic density (Stevens KN, 2012, 1 SNP, EUR) Mathematical ability in children with dyslexia (Ludwig KU, 2013, 1 SNP, EUR) Matrix metalloproteinase levels (Cheng YC, 2009, 4 SNPs, EUR) Mean corpuscular hemoglobin (Ganesh SK, 2009, 9 SNPs, EUR) Mean corpuscular hemoglobin (Kamatani Y, 2010, 15 SNPs, ASN) Mean corpuscular hemoglobin (Li J, 2012, 10 SNPs) mean corpuscular hemoglobin concentration (Kamatani Y, 2010, 7 SNPs, ASN) Mean corpuscular hemoglobin concentration (Li J, 2012, 6 SNPs) Mean corpuscular volume (Ganesh SK, 2009, 17 SNPs, EUR) Mean corpuscular volume (Kamatani Y, 2010, 17 SNPs, ASN) Mean corpuscular volume (Li J, 2012, 10 SNPs) Mean forced vital capacity from 2 exams (Wilk JB, 2007, 2 SNPs, EUR) Mean platelet volume (36 loci from 2 studies in EUR) Mean platelet volume (Gieger C, 2011, 29 SNPs, EUR) Mean platelet volume (Meisinger C, 2008, 3 SNPs, EUR) Mean platelet volume (Qayyum R, 2012, 13 SNPs, AFR) Mean platelet volume (Soranzo N, 2009, 1 SNP, EUR) Mean platelet volume (Soranzo N, 2009, 15 SNPs, EUR) Melanoma (17 loci from 7 studies in EUR) Melanoma (Amos CI, 2011, 1 SNP, EUR) Melanoma (Barrett JH, 2011, 10 SNPs, EUR) Melanoma (Bishop DT, 2009, 5 SNPs, EUR) Melanoma (Brown KM, 2008, 1 SNP, EUR) Melanoma (Iles MM, 2013, 1 SNP, EUR) Melanoma (Macgregor S, 2011, 2 SNPs, EUR) Melanoma (Teerlink C, 2011, 1 SNP, EUR) Menarche (age at onset) (43 loci from 2 studies in EUR) Menarche (age at onset) (Demerath EW, 2013, 15 SNPs, AFR) Menarche (age at onset) (Elks CE, 2010, 42 SNPs, EUR) Menarche (age at onset) (Ong KK, 2009, 1 SNP, EUR) Menarche (age at onset) (Perry JR, 2009, 2 SNPs, EUR) Menarche (age at onset) (Sulem P, 2009, 1 SNP, EUR) Menarche (age at onset) (Tanikawa C, 2013, 8 SNPs, ASN) Menarche and menopause (age at onset) (He C, 2009, 6 SNPs, EUR) Meningioma (Dobbins SE, 2011, 1 SNP, EUR) Meningococcal disease (Davila S, 2010, 1 SNP, EUR) Menopause (age at onset) (33 loci from 3 studies in EUR) Menopause (age at onset) (Perry JR, 2013, 8 SNPs, EUR) Menopause (age at onset) (Stolk L, 2009, 13 SNPs, EUR) Menopause (age at onset) (Stolk L, 2012, 19 SNPs, EUR) Metabolic syndrome (24 loci from 2 studies in EUR) Metabolic syndrome (bivariate traits) (Kraja AT, 2011, 16 SNPs, EUR) Metabolic syndrome (Kraja AT, 2011, 5 SNPs, EUR) Metabolic syndrome (Kristiansson K, 2012, 22 SNPs, EUR) Metabolic syndrome (Zabaneh D, 2010, 18 SNPs) Metabolic traits (47 loci from 2 studies in EUR) Metabolic traits (Sabatti C, 2008, 11 SNPs, EUR) Metabolic traits (Suhre K, 2011, 37 SNPs, EUR) Metabolite levels (5-HIAA) (Luykx JJ, 2013, 13 SNPs, EUR) Metabolite levels (5-HIAA/ MHPG Ratio) (Luykx JJ, 2013, 11 SNPs, EUR) Metabolite levels (71 loci from 7 studies in EUR) Metabolite levels (Gieger C, 2008, 16 SNPs, EUR) Metabolite levels (Hong MG, 2013, 9 SNPs, EUR) Metabolite levels (HVA) (Luykx JJ, 2013, 13 SNPs, EUR) Metabolite levels (HVA-5-HIAA Factor score) (Luykx JJ, 2013, 12 SNPs, EUR) Metabolite levels (HVA/5-HIAA ratio) (Luykx JJ, 2013, 9 SNPs, EUR) Metabolite levels (HVA/MHPG ratio) (Luykx JJ, 2013, 25 SNPs, EUR) Metabolite levels (Illig T, 2009, 5 SNPs, EUR) Metabolite levels (Inouye M, 2012, 34 SNPs, EUR) Metabolite levels (Kettunen J, 2012, 13 SNPs, EUR) Metabolite levels (Kim YJ, 2011, 18 SNPs, ASN) Metabolite levels (MHPG) (Luykx JJ, 2013, 20 SNPs, EUR) Metabolite levels (Nicholson G, 2011, 3 SNPs, EUR) Metabolite levels (Xie W, 2013, 6 SNPs, EUR) Methamphetamine dependence (Ikeda M, 2013, 1 SNP, ASN) Methotrexate clearance (acute lymphoblastic leukemia) (Ramsey LB, 2012, 1 SNP) Methotrexate phramacokinetics (acute lymphoblastic leukemia) (Trevino LR, 2009, 21 SNPs) Migraine (13 loci from 4 studies in EUR) Migraine (Anttila V, 2010, 1 SNP, EUR) Migraine (Chasman DI, 2011, 3 SNPs, EUR) Migraine (Freilinger T, 2012, 10 SNPs, EUR) Migraine (Ligthart L, 2011, 2 SNPs, EUR) Monocyte chemoattractant protein-1 (Voruganti VS, 2012, 5 SNPs, AMR) Monocyte count (Crosslin DR, 2013, 6 SNPs, EUR) Monocyte early outgrowth colony forming units (Shaw SY, 2011, 3 SNPs, EUR) Morbidity-free survival (Lunetta KL, 2007, 5 SNPs, EUR) Mortality among heart failure patients (Morrison AC, 2010, 11 SNPs, EUR) Moyamoya disease (Kamada F, 2010, 1 SNP, ASN) MRI atrophy measures (Furney SJ, 2010, 13 SNPs, EUR) Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma) (Jin G, 2012, 7 SNPs, ASN) Multiple myeloma (Broderick P, 2011, 3 SNPs, EUR) Multiple myeloma (hyperdiploidy) (Weinhold N, 2013, 14 SNPs, EUR) Multiple myeloma (IgH translocation) (Weinhold N, 2013, 25 SNPs, EUR) Multiple sclerosis (144 loci from 14 studies in EUR) Multiple sclerosis (age of onset) (Baranzini SE, 2008, 8 SNPs, EUR) Multiple sclerosis (Aulchenko YS, 2008, 1 SNP, EUR) Multiple sclerosis (Bahlo, 2009, 8 SNPs, EUR) Multiple sclerosis (Baranzini SE, 2008, 10 SNPs, EUR) Multiple sclerosis (Briggs FB, 2011, 6 SNPs, EUR) Multiple sclerosis (Comabella M, 2008, 1 SNP, EUR) Multiple sclerosis (De Jager PL, 2009, 15 SNPs, EUR) Multiple sclerosis (Gourraud PA, 2013, 16 SNPs, EUR) Multiple sclerosis (Hafler DA, 2007, 6 SNPs, EUR) Multiple sclerosis (Jakkula E, 2010, 2 SNPs, EUR) Multiple sclerosis (Martinelli-Boneschi F, 2012, 1 SNP, EUR) Multiple sclerosis (Matesanz F, 2012, 1 SNP, EUR) Multiple sclerosis (Nischwitz S, 2010, 4 SNPs, EUR) Multiple sclerosis (OCB status) (Mero IL, 2013, 11 SNPs, EUR) Multiple sclerosis (Patsopoulos NA, 2011, 19 SNPs, EUR) Multiple sclerosis (Sanna S, 2010, 2 SNPs, EUR) Multiple sclerosis (Sawcer S, 2011, 87 SNPs, EUR) Multiple sclerosis (severity) (12 loci from 2 studies in EUR) Multiple sclerosis (severity) (Baranzini SE, 2008, 11 SNPs, EUR) Multiple sclerosis (severity) (Brynedal B, 2010, 1 SNP, EUR) Multiple sclerosis (Wang JH, 2011, 3 SNPs, EUR) Multiple sclerosis--Brain Glutamate Levels (Baranzini SE, 2010, 5 SNPs, EUR) Myasthenia gravis (Gregersen PK, 2012, 6 SNPs, EUR) Myeloproliferative neoplasms (Kilpivaara O, 2009, 1 SNP) Myocardial infarction (Aoki A, 2010, 1 SNP, ASN) Myocardial infarction (early onset) (Kathiresan S, 2009, 9 SNPs, EUR) Myocardial infarction (Helgadottir A, 2007, 1 SNP, EUR) Myopia (pathological) (11 loci from 6 studies in ASN) Myopia (pathological) (Fan Q, 2012, 4 SNPs, ASN) Myopia (pathological) (Li YJ, 2010, 1 SNP, ASN) Myopia (pathological) (Li Z, 2011, 2 SNPs, ASN) Myopia (pathological) (Meng W, 2012, 64 SNPs, EUR) Myopia (pathological) (Nakanishi H, 2009, 1 SNP, ASN) Myopia (pathological) (Shi Y, 2011, 1 SNP, ASN) Myopia (pathological) (Shi Y, 2013, 5 SNPs, ASN) N-glycan levels (Lauc G, 2010, 8 SNPs, EUR) Narcolepsy (2 loci from 2 studies in EUR) Narcolepsy (Hallmayer J, 2009, 1 SNP, EUR) Narcolepsy (Hor H, 2010, 2 SNPs, EUR) Narcolepsy (Miyagawa T, 2008, 1 SNP, ASN) Narcolepsy with cataplexy (Luca G, 2013, 4 SNPs, EUR) Nasopharyngeal carcinoma (11 loci from 3 studies in ASN) Nasopharyngeal carcinoma (Bei JX, 2010, 7 SNPs, ASN) Nasopharyngeal carcinoma (Ng CC, 2009, 1 SNP, ASN) Nasopharyngeal carcinoma (Tang M, 2012, 6 SNPs, ASN) Nasopharyngeal carcinoma (Tse KP, 2009, 3 SNPs, ASN) Natriuretic peptide levels (Del Greco M F, 2011, 3 SNPs, EUR) Neonatal lupus (Clancy RM, 2010, 5 SNPs, EUR) Nephrolithiasis (Urabe Y, 2012, 3 SNPs, ASN) Nephropathy (Feehally J, 2010, 1 SNP, EUR) Nephropathy (Gharavi AG, 2011, 5 SNPs, ASN) Nephropathy (idiopathic membranous) (Stanescu HC, 2011, 2 SNPs, EUR) Nephrotic syndrome (acquired) (Okamoto K, 2011, 2 SNPs, ASN) Neuranatomic and neurocognitive phenotypes (Carless MA, 2011, 1 SNP, AMR) Neuroblastoma (7 loci from 3 studies in EUR) Neuroblastoma (Diskin SJ, 2012, 6 SNPs, EUR) Neuroblastoma (high-risk) (Capasso M, 2009, 1 SNP, EUR) Neuroblastoma (Maris JM, 2008, 1 SNP, EUR) Neuroblastoma (Wang K, 2010, 3 SNPs, EUR) Neuroticism (8 loci from 4 studies in EUR) Neuroticism (Aragam N, 2012, 1 SNP, EUR) Neuroticism (Calboli FC, 2010, 3 SNPs, EUR) Neuroticism (Shifman S, 2007, 1 SNP, EUR) Neuroticism (van den Oord EJ, 2008, 3 SNPs, EUR) Neutrophil count (Okada Y, 2010, 2 SNPs, ASN) Neutrophil count (Ramsuran V, 2011, 20 SNPs, AFR) Nevirapine-induced rash (Chantarangsu S, 2011, 3 SNPs, ASN) Nicotine dependence (Bierut LJ, 2006, 2 SNPs) Nicotine dependence (Rice JP, 2012, 1 SNP) Nicotine dependence (Thorgeirsson TE, 2008, 1 SNP, EUR) Nodular sclerosis Hodgkin lymphoma (Cozen W, 2011, 2 SNPs, EUR) Non-albumin protein levels (Osman W, 2012, 5 SNPs, ASN) Non-alcoholic fatty liver disease (Kitamoto T, 2013, 4 SNPs, ASN) Non-alcoholic fatty liver disease histology (AST) (Chalasani N, 2010, 6 SNPs, EUR) Non-alcoholic fatty liver disease histology (lobular) (Chalasani N, 2010, 13 SNPs, EUR) Non-alcoholic fatty liver disease histology (other) (19 loci from 2 studies in EUR) Non-alcoholic fatty liver disease histology (other) (Adams LA, 2012, 4 SNPs, EUR) Non-alcoholic fatty liver disease histology (other) (Chalasani N, 2010, 16 SNPs, EUR) Non-melanoma skin cancer (Zhang M, 2013, 4 SNPs, EUR) Non-obstructive azoospermia (5 loci from 2 studies in ASN) Non-obstructive azoospermia (Hu Z, 2011, 4 SNPs, ASN) Non-obstructive azoospermia (Zhao H, 2012, 1 SNP, ASN) Non-small cell lung cancer (19 loci from 4 studies in ASN) Non-small cell lung cancer (Ahn MJ, 2011, 1 SNP, ASN) Non-small cell lung cancer (Lee Y, 2012, 12 SNPs, ASN) Non-small cell lung cancer (Sato Y, 2010, 3 SNPs, ASN) Non-small cell lung cancer (Yoon KA, 2010, 3 SNPs, ASN) Nonalcoholic fatty liver disease (Kawaguchi T, 2012, 5 SNPs, ASN) Nonalcoholic fatty liver disease (Speliotes EK, 2011, 1 SNP, EUR) Normalized brain volume (Baranzini SE, 2008, 5 SNPs, EUR) Obesity (4 loci from 2 studies in ASN) Obesity (56 loci from 5 studies in EUR) Obesity (Berndt SI, 2013, 66 SNPs, EUR) Obesity (Bradfield JP, 2012, 5 SNPs, EUR) Obesity (Dorajoo R, 2011, 1 SNP, ASN) Obesity (early onset extreme) (Hinney A, 2007, 1 SNP, EUR) Obesity (early onset extreme) (Wheeler E, 2013, 18 SNPs, EUR) Obesity (extreme) (18 loci from 3 studies in EUR) Obesity (extreme) (Cotsapas C, 2009, 13 SNPs, EUR) Obesity (extreme) (Paternoster L, 2011, 4 SNPs, EUR) Obesity (extreme) (Scherag A, 2010, 2 SNPs, EUR) Obesity (Jiao H, 2011, 2 SNPs, EUR) Obesity (Kim HJ, 2012, 3 SNPs, ASN) Obesity (Meyre D, 2009, 5 SNPs, EUR) Obesity (Wang K, 2011, 14 SNPs, EUR) Obesity and blood pressure (Melka MG, 2011, 5 SNPs, EUR) Obesity and osteoporosis (Liu YZ, 2009, 2 SNPs, EUR) Obesity-related traits (Comuzzie AG, 2012, 949 SNPs, AMR) Obesity-related traits (Scuteri A, 2007, 3 SNPs, EUR) Obsessive-compulsive disorder (Stewart SE, 2012, 3 SNPs, EUR) Oleic acid (18:1n-9) plasma levels (Wu JH, 2013, 9 SNPs, EUR) Opioid sensitivity (Nishizawa D, 2012, 1 SNP, ASN) Optic disc parameters (Khor CC, 2011, 3 SNPs) Optic disc parameters (Ramdas WD, 2010, 3 SNPs, EUR) Optic disc size (cup) (Macgregor S, 2010, 9 SNPs, EUR) Optic disc size (disc) (Macgregor S, 2010, 7 SNPs, EUR) Optic disc size (rim) (Macgregor S, 2010, 6 SNPs, EUR) Orofacial clefts (27 loci from 3 studies in EUR) Orofacial clefts (Birnbaum S, 2009, 2 SNPs, EUR) Orofacial clefts (Grant SF, 2009, 2 SNPs, EUR) Orofacial clefts (interaction) (Beaty TH, 2011, 2 SNPs) Orofacial clefts (Ludwig KU, 2012, 31 SNPs, EUR) Orofacial clefts (Mangold E, 2009, 6 SNPs, EUR) Orofacial clefts (Shi M, 2012, 17 SNPs) Osteoarthritis (8 loci from 5 studies in EUR) Osteoarthritis (Castano Betancourt MC, 2012, 1 SNP, EUR) Osteoarthritis (Day-Williams AG, 2011, 1 SNP, EUR) Osteoarthritis (Evangelou E, 2010, 1 SNP, EUR) Osteoarthritis (Kerkhof HJ, 2010, 1 SNP, EUR) Osteoarthritis (Loughlin, 2012, 4 SNPs, EUR) Osteonecrosis of the jaw (Sarasquete ME, 2008, 1 SNP, EUR) Osteoporosis (3 loci from 3 studies in ASN) Osteoporosis (Guo Y, 2010, 1 SNP, ASN) Osteoporosis (Hsu YH, 2010, 7 SNPs, EUR) Osteoporosis (Hwang JY, 2013, 1 SNP, ASN) Osteoporosis (Kou I, 2011, 1 SNP, ASN) Osteoporosis-related phenotypes (Karasik D, 2010, 1 SNP, EUR) Osteosarcoma (Savage SA, 2013, 6 SNPs, EUR) Other erythrocyte phenotypes (Ganesh SK, 2009, 4 SNPs, EUR) Otosclerosis (Schrauwen I, 2009, 1 SNP, EUR) Ovarian cancer (13 loci from 3 studies in EUR) Ovarian cancer (Bolton KL, 2010, 2 SNPs, EUR) Ovarian cancer (Goode EL, 2010, 7 SNPs, EUR) Ovarian cancer (Pharoah PD, 2013, 17 SNPs, EUR) Ovarian cancer (Song H, 2009, 1 SNP, EUR) Ovarian cancer in BRCA1 mutation carriers (Couch FJ, 2013, 7 SNPs, EUR) Ovarian reserve (Schuh-Huerta SM, 2011, 7 SNPs) P-tau181p (Han MR, 2010, 5 SNPs, EUR) Paget's disease (10 loci from 2 studies in EUR) Paget's disease (Albagha OM, 2010, 4 SNPs, EUR) Paget's disease (Albagha OM, 2011, 9 SNPs, EUR) Pain (4 loci from 2 studies in EUR) Pain (Kim H, 2009, 3 SNPs, EUR) Pain (Peters MJ, 2012, 1 SNP, EUR) Palmitic acid (16:0) plasma levels (Wu JH, 2013, 12 SNPs, EUR) Palmitoleic acid (16:1n-7) plasma levels (Wu JH, 2013, 15 SNPs, EUR) Pancreatic cancer (11 loci from 3 studies in EUR) Pancreatic cancer (28 loci from 2 studies in ASN) Pancreatic cancer (Amundadottir L, 2009, 1 SNP, EUR) Pancreatic cancer (Low SK, 2010, 17 SNPs, ASN) Pancreatic cancer (Petersen GM, 2010, 3 SNPs, EUR) Pancreatic cancer (Wu C, 2011, 11 SNPs, ASN) Pancreatic cancer (Wu C, 2012, 7 SNPs, EUR) Pancreatitis (Whitcomb DC, 2012, 5 SNPs, ASN) Panic disorder (Otowa T, 2009, 17 SNPs, ASN) Paraoxonase activity (Tang WH, 2012, 2 SNPs, EUR) Parkinson's disease (51 loci from 11 studies in EUR) Parkinson's disease (age of onset) (Latourelle JC, 2009, 5 SNPs, EUR) Parkinson's disease (Do CB, 2011, 11 SNPs, EUR) Parkinson's disease (Edwards TL, 2010, 6 SNPs, EUR) Parkinson's disease (familial) (Pankratz N, 2008, 1 SNP, EUR) Parkinson's disease (Fung HC, 2006, 3 SNPs) Parkinson's disease (Hamza TH, 2010, 4 SNPs, EUR) Parkinson's disease (Lill CM, 2012, 6 SNPs, EUR) Parkinson's disease (Liu X, 2011, 3 SNPs, EUR) Parkinson's disease (Maraganore DM, 2005, 1 SNP, EUR) Parkinson's disease (motor and cognition) (Chung SJ, 2012, 5 SNPs, EUR) Parkinson's disease (Nalls MA, 2011, 11 SNPs, EUR) Parkinson's disease (Pankratz N, 2012, 17 SNPs, EUR) Parkinson's disease (Saad M, 2010, 3 SNPs, EUR) Parkinson's disease (Satake W, 2009, 4 SNPs, ASN) Parkinson's disease (Simon-Sanchez J, 2009, 10 SNPs, EUR) Parkinson's disease (Spencer CC, 2010, 3 SNPs, EUR) Partial epilepsies (Kasperaviciute D, 2010, 6 SNPs, EUR) PCA3 expression level (Chen Z, 2013, 4 SNPs, EUR) Pericardial fat (Fox CS, 2012, 1 SNP, EUR) Periodontal microbiota (Divaris K, 2012, 16 SNPs, EUR) Periodontitis (4 loci from 2 studies in EUR) Periodontitis (Divaris K, 2013, 3 SNPs, EUR) Periodontitis (Schaefer AS, 2009, 1 SNP, EUR) Peripheral artery disease (Koriyama H, 2010, 2 SNPs, ASN) Permanent tooth development (Geller F, 2011, 4 SNPs, EUR) Personality dimensions (19 loci from 4 studies in EUR) Personality dimensions (Alliey-Rodriguez N, 2011, 7 SNPs, EUR) Personality dimensions (Bae HT, 2013, 2 SNPs, EUR) Personality dimensions (de Moor MH, 2010, 2 SNPs, EUR) Personality dimensions (Terracciano A, 2008, 5 SNPs, EUR) Personality dimensions (Verweij KJ, 2010, 7 SNPs, EUR) Phospholipid levels (plasma) (46 loci from 2 studies in EUR) Phospholipid levels (plasma) (Demirkan A, 2012, 25 SNPs, EUR) Phospholipid levels (plasma) (Lemaitre RN, 2011, 50 SNPs, EUR) Phosphorus levels (Kestenbaum B, 2010, 5 SNPs, EUR) Phytosterol levels (Teupser D, 2010, 3 SNPs, EUR) Pit-and-Fissure caries (Zeng Z, 2013, 8 SNPs, EUR) Plasminogen activator inhibitor type 1 levels (PAI-1) (Huang J, 2012, 4 SNPs, EUR) Platelet aggregation (Johnson AD, 2010, 15 SNPs, EUR) Platelet counts (Gieger C, 2011, 56 SNPs, EUR) Platelet counts (Kamatani Y, 2010, 7 SNPs, ASN) Platelet counts (Li J, 2012, 8 SNPs) Platelet counts (Ramsuran V, 2011, 10 SNPs, AFR) Platelet function and related traits (Guerrero JA, 2011, 1 SNP, EUR) Polycystic ovary syndrome (13 loci from 2 studies in ASN) Polycystic ovary syndrome (Chen ZJ, 2010, 5 SNPs, ASN) Polycystic ovary syndrome (Shi Y, 2012, 11 SNPs, ASN) Post-traumatic stress disorder (asjusted for relatedness) (Xie P, 2013, 19 SNPs) Post-traumatic stress disorder (Xie P, 2013, 2 SNPs) PR interval (16 loci from 2 studies in AFR) PR interval (Butler AM, 2012, 8 SNPs, AFR) PR interval (Jeff JM, 2013, 9 SNPs, AFR) PR interval (Pfeufer A, 2010, 9 SNPs, EUR) PR interval (Smith JG, 2011, 1 SNP, AFR) Preeclampsia (Zhao L, 2013, 18 SNPs) Premature ovarian failure (Qin Y, 2011, 1 SNP, ASN) Presence of antiphospholipid antibodies (Kamboh MI, 2013, 13 SNPs, EUR) Primary biliary cirrhosis (25 loci from 3 studies in EUR) Primary biliary cirrhosis (Hirschfield GM, 2009, 7 SNPs, EUR) Primary biliary cirrhosis (Liu X, 2010, 6 SNPs, EUR) Primary biliary cirrhosis (Mells GF, 2011, 21 SNPs, EUR) Primary biliary cirrhosis (Nakamura M, 2012, 7 SNPs, ASN) Primary sclerosing cholangitis (Melum E, 2010, 2 SNPs, EUR) Primary tooth development (number of teeth) (13 loci from 2 studies in EUR) Primary tooth development (number of teeth) (Fatemifar G, 2013, 11 SNPs, EUR) Primary tooth development (number of teeth) (Pillas D, 2010, 9 SNPs, EUR) Primary tooth development (time to first tooth eruption) (13 loci from 2 studies in EUR) Primary tooth development (time to first tooth eruption) (Fatemifar G, 2013, 13 SNPs, EUR) Primary tooth development (time to first tooth eruption) (Pillas D, 2010, 6 SNPs, EUR) Prion diseases (Mead S, 2011, 11 SNPs, EUR) Progranulin levels (Carrasquillo MM, 2010, 1 SNP, EUR) Progressive supranuclear palsy (Hoglinger GU, 2011, 11 SNPs, EUR) Proinsulin levels (Strawbridge RJ, 2011, 10 SNPs, EUR) Prostate cancer (13 loci from 2 studies in ASN) Prostate cancer (76 loci from 12 studies in EUR) Prostate cancer (Amin Al Olama A, 2012, 4 SNPs, EUR) Prostate cancer (Cheng I, 2012, 8 SNPs) Prostate cancer (Eeles RA, 2008, 12 SNPs, EUR) Prostate cancer (Eeles RA, 2009, 19 SNPs, EUR) Prostate cancer (Eeles RA, 2013, 23 SNPs, EUR) Prostate cancer (gene x gene interaction) (Tao S, 2012, 51 SNPs) Prostate cancer (Gudmundsson J, 2007, 2 SNPs, EUR) Prostate cancer (Gudmundsson J, 2007, 3 SNPs, EUR) Prostate cancer (Gudmundsson J, 2008, 2 SNPs, EUR) Prostate cancer (Gudmundsson J, 2009, 8 SNPs, EUR) Prostate cancer (Haiman CA, 2011, 1 SNP, AFR) Prostate cancer (Kote-Jarai Z, 2011, 9 SNPs, EUR) Prostate cancer (Murabito JM, 2007, 5 SNPs, EUR) Prostate cancer (Nam RK, 2011, 2 SNPs, EUR) Prostate cancer (Schumacher FR, 2011, 14 SNPs, EUR) Prostate cancer (Sun J, 2009, 1 SNP, EUR) Prostate cancer (Takata R, 2010, 11 SNPs, ASN) Prostate cancer (Thomas G, 2008, 7 SNPs, EUR) Prostate cancer (Xu J, 2012, 3 SNPs, ASN) Prostate cancer (Yeager M, 2007, 2 SNPs, EUR) Prostate-specific antigen levels (9 loci from 2 studies in EUR) Prostate-specific antigen levels (Gudmundsson J, 2010, 7 SNPs, EUR) Prostate-specific antigen levels (Jin G, 2013, 2 SNPs, EUR) Prostate-specific antigen levels (Sun J, 2012, 3 SNPs, ASN) Protein biomarker (de Boer RA, 2012, 2 SNPs, EUR) Protein C levels (Tang W, 2010, 4 SNPs, EUR) Protein quantitative trait loci (Melzer D, 2008, 49 SNPs, EUR) Prothrombin time (Tang W, 2012, 2 SNPs, EUR) Psoriasis (31 loci from 6 studies in EUR) Psoriasis (Capon F, 2008, 2 SNPs, EUR) Psoriasis (Ellinghaus E, 2010, 3 SNPs, EUR) Psoriasis (Liu Y, 2008, 3 SNPs, EUR) Psoriasis (Nair RP, 2009, 8 SNPs, EUR) Psoriasis (Strange A, 2010, 17 SNPs, EUR) Psoriasis (Stuart PE, 2010, 8 SNPs, EUR) Psoriasis (Zhang XJ, 2009, 3 SNPs, ASN) Psoriatic arthritis (5 loci from 2 studies in EUR) Psoriatic arthritis (Ellinghaus E, 2011, 2 SNPs, EUR) Psoriatic arthritis (Huffmeier U, 2010, 3 SNPs, EUR) Psychosis (methamphetamine induced) (Ikeda M, 2013, 1 SNP, ASN) Pubertal anthropometrics (Cousminer DL, 2013, 25 SNPs, EUR) Pulmonary arterial hypertension (without BMPR2 mutations) (Germain M, 2013, 1 SNP, EUR) Pulmonary function (49 loci from 4 studies in EUR) Pulmonary function (Hancock DB, 2009, 8 SNPs, EUR) Pulmonary function (interaction) (Hancock DB, 2012, 53 SNPs, EUR) Pulmonary function (Repapi E, 2009, 7 SNPs, EUR) Pulmonary function (Soler Artigas M, 2011, 33 SNPs, EUR) Pulmonary function (Wilk JB, 2007, 10 SNPs, EUR) Pulmonary function (Wilk JB, 2009, 1 SNP, EUR) Pulmonary function decline (Imboden M, 2012, 39 SNPs, EUR) Pulmonary function in asthmatics (Li X, 2013, 4 SNPs, EUR) QRS duration (Jeff JM, 2013, 9 SNPs, AFR) QT interval (34 loci from 2 studies in AFR) QT interval (35 loci from 5 studies in EUR) QT interval (Arking DE, 2006, 1 SNP, EUR) QT interval (interaction) (Avery CL, 2013, 17 SNPs, EUR) QT interval (Jeff JM, 2013, 8 SNPs, AFR) QT interval (Kim JW, 2012, 3 SNPs, ASN) QT interval (Marroni F, 2009, 14 SNPs, EUR) QT interval (Newton-Cheh C, 2009, 13 SNPs, EUR) QT interval (Nolte IM, 2009, 2 SNPs, EUR) QT interval (Pfeufer A, 2009, 12 SNPs, EUR) QT interval (Smith JG, 2012, 29 SNPs, AFR) Quantitative traits (Lowe JK, 2009, 33 SNPs, ASN) Radiation response (Niu N, 2010, 12 SNPs) Reasoning (McClay JL, 2010, 10 SNPs, EUR) Recombination rate (females) (Kong A, 2008, 1 SNP, EUR) Recombination rate (males) (Kong A, 2008, 1 SNP, EUR) Red blood cell count (Kamatani Y, 2010, 8 SNPs, ASN) Red blood cell traits (49 loci from 2 studies in EUR) Red blood cell traits (Chen Z, 2013, 15 SNPs, AFR) Red blood cell traits (Ding K, 2013, 7 SNPs, AFR) Red blood cell traits (Kullo IJ, 2010, 13 SNPs, EUR) Red blood cell traits (van der Harst P, 2012, 45 SNPs, EUR) Red vs non-red hair color (Sulem P, 2007, 1 SNP, EUR) Red vs. non-red hair color (Sulem P, 2008, 1 SNP, EUR) Refractive error (26 loci from 2 studies in EUR) Refractive error (Hysi PG, 2010, 1 SNP, EUR) Refractive error (Solouki AM, 2010, 1 SNP, EUR) Refractive error (Stambolian D, 2013, 1 SNP, EUR) Refractive error (Verhoeven VJ, 2013, 26 SNPs, EUR) Renal cell carcinoma (8 loci from 3 studies in EUR) Renal cell carcinoma (Henrion M, 2012, 2 SNPs, EUR) Renal cell carcinoma (Purdue MP, 2010, 3 SNPs, EUR) Renal cell carcinoma (Wu X, 2011, 3 SNPs, EUR) Renal function and chronic kidney disease (Kottgen A, 2009, 4 SNPs, EUR) Renal function-related traits (BUN) (Okada Y, 2012, 15 SNPs, ASN) Renal function-related traits (eGRFcrea) (Okada Y, 2012, 10 SNPs, ASN) Renal function-related traits (sCR) (Okada Y, 2012, 9 SNPs, ASN) Renal function-related traits (urea) (Okada Y, 2012, 4 SNPs, ASN) Renal sinus fat (Foster MC, 2011, 8 SNPs, EUR) Renal transplant outcome (O'Brien RP, 2013, 4 SNPs, EUR) Resistin levels (Qi Q, 2012, 4 SNPs, EUR) Response to acetaminophen (hepatotoxicity) (Moyer AM, 2010, 5 SNPs) Response to amphetamines (Hart AB, 2012, 89 SNPs) Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy) (Turner ST, 2012, 5 SNPs) Response to angiotensin II receptor blocker therapy (Turner ST, 2012, 20 SNPs) Response to anti-TNF alpha therapy in inflammatory bowel disease (Dubinsky MC, 2010, 4 SNPs) Response to anti-TNF treatment in rheumatoid arthritis (Cui J, 2013, 5 SNPs, EUR) Response to antidepressant treatment (citalopram) (Hunter AM, 2013, 3 SNPs) Response to antidepressant treatment (Clark SL, 2011, 22 SNPs, EUR) Response to antidepressants (Sasayama D, 2012, 1 SNP, ASN) Response to antidepressants (Uher R, 2010, 8 SNPs, EUR) Response to antineoplastic agents (Wade R, 2011, 9 SNPs, EUR) Response to antipsychotic therapy (extrapyramidal side effects) (Aberg K, 2009, 17 SNPs) Response to antipsychotic therapy (extrapyramidal side effects) (Drago A, 2011, 1 SNP, EUR) Response to antipsychotic treatment (11 loci from 3 studies in EUR) Response to antipsychotic treatment (Adkins DE, 2010, 37 SNPs) Response to antipsychotic treatment (Alkelai A, 2009, 1 SNP, EUR) Response to antipsychotic treatment (Clark SL, 2012, 8 SNPs) Response to antipsychotic treatment (McClay JL, 2009, 9 SNPs, EUR) Response to antipsychotic treatment (McClay JL, 2010, 2 SNPs, EUR) Response to cerivastatin (Marciante KD, 2011, 1 SNP, EUR) Response to cholinesterase inhibitors in Alzheimer's disease (Martinelli-Boneschi F, 2013, 3 SNPs, EUR) Response to citalopram treatment (Adkins DE, 2012, 17 SNPs, EUR) Response to citalopram treatment (Garriock HA, 2009, 7 SNPs) Response to clopidogrel therapy (Shuldiner AR, 2009, 1 SNP, EUR) Response to dabigatran etexilate treatment (Pare G, 2013, 2 SNPs, EUR) Response to diuretic therapy (Turner ST, 2008, 1 SNP) Response to diuretic therapy in hypertension (Turner ST, 2013, 1 SNP, EUR) Response to fenofibrate (adiponectin levels) (Aslibekyan S, 2012, 12 SNPs, ASN) Response to fenofibrate (Frazier-Wood AC, 2012, 10 SNPs, EUR) Response to gemcitabine in pancreatic cancer (Innocenti F, 2011, 3 SNPs, EUR) Response to gemcitabine in pancreatic cancer (Kiyotani K, 2012, 2 SNPs, ASN) Response to hepatitis C treatment (13 loci from 3 studies in EUR) Response to hepatitis C treatment (2 loci from 2 studies in ASN) Response to hepatitis C treatment (Ge D, 2009, 3 SNPs, EUR) Response to hepatitis C treatment (Lange CM, 2011, 9 SNPs, EUR) Response to hepatitis C treatment (Ochi H, 2011, 1 SNP, ASN) Response to hepatitis C treatment (Suppiah V, 2009, 1 SNP, EUR) Response to hepatitis C treatment (Tanaka Y, 2009, 1 SNP, ASN) Response to hepatitis C treatment (Tanaka Y, 2011, 4 SNPs, ASN) Response to iloperidone treatment (QT prolongation) (Volpi S, 2008, 6 SNPs) Response to interferon beta therapy (Weber F, 2011, 2 SNPs, EUR) Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer (Han JY, 2013, 7 SNPs, ASN) Response to irinotecan in non-small-cell lung cancer (Han JY, 2012, 2 SNPs, ASN) Response to metformin (Florez JC, 2011, 1 SNP, EUR) Response to metformin (Zhou K, 2010, 1 SNP, EUR) Response to platinum-based agents (Won HH, 2011, 3 SNPs, ASN) Response to platinum-based chemotherapy in head and neck cancers (Ziliak D, 2011, 2 SNPs, EUR) Response to platinum-based chemotherapy in non-small-cell lung cancer (Hu L, 2012, 5 SNPs, ASN) Response to platinum-based chemotherapy in non-small-cell lung cancer (Wu X, 2011, 1 SNP, EUR) Response to statin therapy (37 loci from 4 studies in EUR) Response to statin therapy (Barber MJ, 2010, 36 SNPs, EUR) Response to statin therapy (Deshmukh HA, 2012, 1 SNP, EUR) Response to statin therapy (LDL-C) (Chasman DI, 2012, 8 SNPs, EUR) Response to statin therapy (Link E, 2008, 1 SNP, EUR) Response to statin therapy (Shiffman D, 2012, 1 SNP, EUR) Response to tamoxifen in breast cancer (Kiyotani K, 2011, 1 SNP, ASN) Response to taxane treatment (docetaxel) (Niu N M D Ph D, 2012, 16 SNPs) Response to taxane treatment (placlitaxel) (Niu N M D Ph D, 2012, 13 SNPs) Response to temozolomide (Brown CC, 2012, 1 SNP, EUR) Response to TNF antagonist treatment (Liu C, 2008, 8 SNPs, EUR) Response to TNF-alpha inhibitors in rheumatoid arthritis (Krintel SB, 2012, 8 SNPs, EUR) Response to tocilizumab in rheumatoid arthritis (Wang J, 2012, 31 SNPs, EUR) Response to treatment for acute lymphoblastic leukemia (Yang JJ, 2009, 12 SNPs, EUR) Response to Vitamin E supplementation (Major JM, 2012, 8 SNPs, EUR) Resting heart rate (Deo R, 2012, 2 SNPs, AFR) Resting heart rate (Eijgelsheim M, 2010, 10 SNPs, EUR) Restless legs syndrome (8 loci from 3 studies in EUR) Restless legs syndrome (Schormair B, 2008, 2 SNPs, EUR) Restless legs syndrome (Stefansson H, 2007, 1 SNP, EUR) Restless legs syndrome (Winkelmann J, 2007, 3 SNPs, EUR) Restless legs syndrome (Winkelmann J, 2011, 6 SNPs, EUR) Retinal arteriolar caliber (Sim X, 2013, 2 SNPs, EUR) Retinal vascular caliber (Ikram MK, 2010, 5 SNPs, EUR) Retinol levels (Mondul AM, 2011, 2 SNPs, EUR) Retinopathy in non-diabetics (Jensen RA, 2013, 11 SNPs, EUR) Rhegmatogenous retinal detachment (Kirin M, 2013, 4 SNPs, EUR) Rheumatoid arthritis (28 loci from 6 studies in ASN) Rheumatoid arthritis (46 loci from 8 studies in EUR) Rheumatoid arthritis (Eleftherohorinou H, 2011, 5 SNPs, EUR) Rheumatoid arthritis (Freudenberg J, 2011, 9 SNPs, ASN) Rheumatoid arthritis (Gregersen PK, 2009, 5 SNPs, EUR) Rheumatoid arthritis (Hu HJ, 2011, 1 SNP, ASN) Rheumatoid arthritis (Julia A, 2008, 2 SNPs, EUR) Rheumatoid arthritis (Kochi Y, 2010, 4 SNPs, ASN) Rheumatoid arthritis (Myouzen K, 2012, 2 SNPs, ASN) Rheumatoid arthritis (Okada Y, 2012, 15 SNPs, ASN) Rheumatoid arthritis (Plenge RM, 2007, 2 SNPs, EUR) Rheumatoid arthritis (Plenge RM, 2007, 3 SNPs, EUR) Rheumatoid arthritis (Raychaudhuri S, 2008, 9 SNPs, EUR) Rheumatoid arthritis (Stahl EA, 2010, 29 SNPs, EUR) Rheumatoid arthritis (Terao C, 2011, 3 SNPs, ASN) Rheumatoid arthritis (WTCCC, 2007, 7 SNPs, EUR) Ribavirin-induced anemia (Ochi H, 2010, 1 SNP, ASN) RR interval (heart rate) (Marroni F, 2009, 20 SNPs, EUR) Sagittal craniosynostosis (Justice CM, 2012, 2 SNPs, EUR) Sarcoidosis (3 loci from 2 studies in EUR) Sarcoidosis (Fischer A, 2012, 1 SNP, EUR) Sarcoidosis (Hofmann S, 2012, 2 SNPs, EUR) Schizophrenia (5 loci from 3 studies in ASN) Schizophrenia (92 loci from 15 studies in EUR) Schizophrenia (Aberg KA, 2013, 14 SNPs, EUR) Schizophrenia (Alkelai A, 2011, 2 SNPs, EUR) Schizophrenia (Athanasiu L, 2010, 3 SNPs, EUR) Schizophrenia (Bergen SE, 2012, 15 SNPs, EUR) Schizophrenia (Betcheva ET, 2012, 1 SNP, EUR) Schizophrenia (Borglum AD, 2013, 3 SNPs, EUR) Schizophrenia (cytomegalovirus infection interaction) (Borglum AD, 2013, 1 SNP, EUR) Schizophrenia (Fanous AH, 2012, 16 SNPs, EUR) Schizophrenia (Irish Schizophrenia Genomics Consortium & the Wellcome Trust Case Control Consortium 2, 2012, 2 SNPs, EUR) Schizophrenia (Kirov G, 2008, 1 SNP, EUR) Schizophrenia (Lencz T, 2007, 1 SNP, EUR) Schizophrenia (Levinson DF, 2012, 11 SNPs, EUR) Schizophrenia (Ma X, 2011, 1 SNP, ASN) Schizophrenia (negative symptoms) (Xu C, 2013, 3 SNPs, EUR) Schizophrenia (O'Donovan MC, 2008, 3 SNPs, EUR) Schizophrenia (Purcell SM, 2009, 4 SNPs, EUR) Schizophrenia (Ripke S, 2011, 25 SNPs, EUR) Schizophrenia (Shi J, 2009, 2 SNPs) Schizophrenia (Shi Y, 2011, 2 SNPs, ASN) Schizophrenia (Shifman S, 2008, 1 SNP, EUR) Schizophrenia (Stefansson H, 2009, 7 SNPs, EUR) Schizophrenia (Sullivan PF, 2008, 6 SNPs) Schizophrenia (treatment refractory) (Liou YJ, 2012, 2 SNPs, ASN) Schizophrenia (Walsh T, 2008, 1 SNP) Schizophrenia (Yue WH, 2011, 2 SNPs, ASN) Schizophrenia, bipolar disorder and depression (combined) (Huang J, 2010, 5 SNPs, EUR) Sclerosing cholangitis and ulcerative colitis (combined) (Ellinghaus D, 2012, 2 SNPs, EUR) Scoliosis (2 loci from 2 studies in ASN) Scoliosis (Kou I, 2013, 2 SNPs, ASN) Scoliosis (Sharma S, 2011, 1 SNP, EUR) Scoliosis (Takahashi Y, 2011, 1 SNP, ASN) Select biomarker traits (Benjamin EJ, 2007, 21 SNPs, EUR) Self-employment (van der Loos MJ, 2013, 2 SNPs, EUR) Self-rated health (Mosing MA, 2010, 10 SNPs, EUR) Serum albumin level (Franceschini N, 2012, 16 SNPs, EUR) Serum ceruloplasmin levels (Tang WH, 2011, 1 SNP, EUR) Serum selenium levels (Gong J, 2013, 4 SNPs, EUR) Serum tamsulosin hydrochloride concentration (Takata R, 2012, 4 SNPs, ASN) Serum total protein level (Franceschini N, 2012, 12 SNPs, EUR) Sex hormone-binding globulin levels (22 loci from 2 studies in EUR) Sex hormone-binding globulin levels (Coviello AD, 2012, 30 SNPs, EUR) Sex hormone-binding globulin levels (Prescott J, 2012, 8 SNPs, EUR) Sexual dysfunction (female) (Burri A, 2012, 3 SNPs, EUR) Sexual dysfunction (SSRI/SNRI-related) (Kurose K, 2012, 5 SNPs, ASN) Sickle cell anemia (haemolysis) (Milton JN, 2013, 4 SNPs, AFR) Skin pigmentation (Stokowski RP, 2007, 3 SNPs) Skin sensitivity to sun (Sulem P, 2007, 2 SNPs, EUR) Skin sensitivity to sun (Sulem P, 2008, 1 SNP, EUR) Sleep depth (Byrne EM, 2013, 2 SNPs, EUR) Sleep duration (9 loci from 2 studies in EUR) Sleep duration (Byrne EM, 2013, 7 SNPs, EUR) Sleep duration (Gottlieb DJ, 2007, 2 SNPs, EUR) Sleep quality (Byrne EM, 2013, 7 SNPs, EUR) Sleep time (Byrne EM, 2013, 5 SNPs, EUR) Sleepiness (Gottlieb DJ, 2007, 2 SNPs, EUR) Small-cell lung cancer (Wu C, 2010, 1 SNP, ASN) Smoking behavior (27 loci from 3 studies in EUR) Smoking behavior (5 loci from 2 studies in ASN) Smoking behavior (Caporaso N, 2009, 21 SNPs, EUR) Smoking behavior (David SP, 2012, 5 SNPs, AFR) Smoking behavior (Kumasaka N, 2012, 3 SNPs, ASN) Smoking behavior (Liu JZ, 2010, 1 SNP, EUR) Smoking behavior (The Tobacco and Genetics Consortium, 2010, 5 SNPs, EUR) Smoking behavior (Thorgeirsson TE, 2010, 5 SNPs, EUR) Smoking behavior (Yoon D, 2011, 6 SNPs, ASN) Smoking cessation (Uhl GR, 2010, 1 SNP, EUR) Smooth-surface caries (Zeng Z, 2013, 11 SNPs, EUR) Soluble E-selectin levels (Paterson AD, 2009, 1 SNP, EUR) Soluble ICAM-1 (4 loci from 2 studies in EUR) Soluble ICAM-1 (Pare G, 2008, 4 SNPs, EUR) Soluble ICAM-1 (Pare G, 2011, 3 SNPs, EUR) Soluble leptin receptor levels (Sun Q, 2010, 1 SNP, EUR) Soluble levels of adhesion molecules (Barbalic M, 2010, 5 SNPs, EUR) Speech perception in dyslexia (Roeske D, 2009, 2 SNPs, EUR) Sphingolipid levels (11 loci from 2 studies in EUR) Sphingolipid levels (Demirkan A, 2012, 10 SNPs, EUR) Sphingolipid levels (Hicks AA, 2009, 5 SNPs, EUR) Spine bone size (Deng FY, 2012, 1 SNP, EUR) Squamous cell carcinoma (Dong J, 2013, 1 SNP, ASN) Stearic acid (18:0) plasma levels (Wu JH, 2013, 11 SNPs, EUR) Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) (Genin E, 2011, 4 SNPs, EUR) Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) (Tohkin M, 2011, 1 SNP, ASN) Stroke (6 loci from 3 studies in EUR) Stroke (Bellenguez C, 2012, 1 SNP, EUR) Stroke (Ikram MA, 2009, 1 SNP, EUR) Stroke (ischemic) (8 loci from 3 studies in EUR) Stroke (ischemic) (Gretarsdottir S, 2008, 1 SNP, EUR) Stroke (ischemic) (Holliday EG, 2012, 1 SNP, EUR) Stroke (ischemic) (Traylor M, 2012, 8 SNPs, EUR) Stroke (Matarin M, 2007, 4 SNPs, EUR) Stroke (pediatric) (Arning A, 2012, 4 SNPs, EUR) Subarachnoid aneurysmal hemorrhage (Bae JS, 2008, 1 SNP, ASN) Subclinical atherosclerosis traits (other) (O'Donnell CJ, 2007, 8 SNPs, EUR) Subcutaneous adipose tissue (Fox CS, 2012, 39 SNPs, EUR) Substance dependence (Chen X, 2011, 1 SNP) Sudden cardiac arrest (50 loci from 2 studies in EUR) Sudden cardiac arrest (Aouizerat BE, 2011, 50 SNPs, EUR) Sudden cardiac arrest (Arking DE, 2011, 1 SNP, EUR) Suicidal ideation (Perroud N, 2010, 4 SNPs, EUR) Suicide attempts in bipolar disorder (Willour VL, 2011, 3 SNPs, EUR) Sunburns (Zhang M, 2013, 4 SNPs, EUR) Systemic lupus erythematosus (41 loci from 6 studies in EUR) Systemic lupus erythematosus (45 loci from 5 studies in ASN) Systemic lupus erythematosus (Chung SA, 2011, 24 SNPs, EUR) Systemic lupus erythematosus (Graham RR, 2008, 8 SNPs, EUR) Systemic lupus erythematosus (Han JW, 2009, 18 SNPs, ASN) Systemic lupus erythematosus (Harley JB, 2008, 6 SNPs, EUR) Systemic lupus erythematosus (Hom G, 2008, 9 SNPs, EUR) Systemic lupus erythematosus (Kozyrev SV, 2008, 1 SNP, EUR) Systemic lupus erythematosus (Lee YH, 2012, 5 SNPs, EUR) Systemic lupus erythematosus (Okada Y, 2012, 2 SNPs, ASN) Systemic lupus erythematosus (Yang J, 2010, 1 SNP, ASN) Systemic lupus erythematosus (Yang W, 2010, 2 SNPs, ASN) Systemic lupus erythematosus (Yang W, 2012, 34 SNPs, ASN) Systemic sclerosis (18 loci from 3 studies in EUR) Systemic sclerosis (Allanore Y, 2011, 7 SNPs, EUR) Systemic sclerosis (Gorlova O, 2011, 18 SNPs, EUR) Systemic sclerosis (Radstake TR, 2010, 4 SNPs, EUR) Systolic blood pressure (28 loci from 3 studies in EUR) Systolic blood pressure (Ehret GB, 2011, 20 SNPs, EUR) Systolic blood pressure (Levy D, 2009, 7 SNPs, EUR) Systolic blood pressure (Newton-Cheh C, 2009, 3 SNPs, EUR) T-tau (Han MR, 2010, 5 SNPs, EUR) Tanning (14 loci from 2 studies in EUR) Tanning (Nan H, 2009, 10 SNPs, EUR) Tanning (Zhang M, 2013, 5 SNPs, EUR) Tardive dyskinesia (Tanaka S, 2011, 1 SNP, ASN) Telomere length (12 loci from 5 studies in EUR) Telomere length (Codd V, 2010, 1 SNP, EUR) Telomere length (Codd V, 2013, 2 SNPs, EUR) Telomere length (Gu J, 2011, 4 SNPs, EUR) Telomere length (Levy D, 2010, 4 SNPs, EUR) Telomere length (Mangino M, 2009, 1 SNP, EUR) Telomere length (Mangino M, 2012, 4 SNPs, EUR) Telomere length (Prescott J, 2011, 1 SNP, EUR) Temperament (bipolar disorder) (Greenwood TA, 2012, 13 SNPs, EUR) Temperament (Service SK, 2012, 16 SNPs, EUR) Temporomandibular joint disorders (Yamaguchi T, 2013, 1 SNP, ASN) Testicular cancer (3 loci from 2 studies in EUR) Testicular cancer (Kanetsky PA, 2009, 1 SNP, EUR) Testicular cancer (Kanetsky PA, 2011, 2 SNPs, EUR) Testicular germ cell cancer (Turnbull C, 2010, 6 SNPs, EUR) Testicular germ cell tumor (21 loci from 3 studies in EUR) Testicular germ cell tumor (Chung CC, 2013, 11 SNPs, EUR) Testicular germ cell tumor (Rapley EA, 2009, 6 SNPs, EUR) Testicular germ cell tumor (Ruark E, 2013, 15 SNPs, EUR) Testosterone levels (6 loci from 2 studies in EUR) Testosterone levels (Ohlsson C, 2011, 2 SNPs, EUR) Testosterone levels (Prescott J, 2012, 5 SNPs, EUR) Tetralogy of Fallot (Cordell HJ, 2013, 6 SNPs, EUR) Thiazide-induced adverse metabolic effects in hypertensive patients (Del-Aguila JL, 2013, 59 SNPs) Thoracic aortic aneurysms and dissections (Lemaire SA, 2011, 1 SNP, EUR) Thyroid cancer (Gudmundsson J, 2009, 2 SNPs) Thyroid cancer (Gudmundsson J, 2012, 3 SNPs, EUR) Thyroid cancer (Papillary, radiation-related) (Takahashi M, 2010, 1 SNP, EUR) Thyroid function (Rawal R, 2012, 4 SNPs, EUR) Thyroid hormone levels (Porcu E, 2013, 60 SNPs, EUR) Thyroid stimulating hormone (4 loci from 2 studies in EUR) Thyroid stimulating hormone (Arnaud-Lopez L, 2008, 1 SNP, EUR) Thyroid stimulating hormone (Hwang SJ, 2007, 3 SNPs, EUR) Thyroid volume (Teumer A, 2011, 8 SNPs, EUR) Thyrotoxic hypokalemic periodic paralysis (Cheung CL, 2012, 1 SNP, ASN) Thyrotoxic hypokalemic periodic paralysis (Jongjaroenprasert W, 2012, 1 SNP, ASN) Tonometry (Levy D, 2007, 13 SNPs, EUR) Total ventricular volume (Furney SJ, 2010, 19 SNPs, EUR) Tourette syndrome (Scharf JM, 2012, 7 SNPs, EUR) TP53 carriage (Shlien A, 2008, 1 SNP, EUR) Treatment response for severe sepsis (Man M, 2012, 8 SNPs) Triglycerides (11 loci from 3 studies in ASN) Triglycerides (47 loci from 8 studies in EUR) Triglycerides (Aulchenko YS, 2008, 8 SNPs, EUR) Triglycerides (Coram MA, 2013, 7 SNPs) Triglycerides (Kamatani Y, 2010, 6 SNPs, ASN) Triglycerides (Kathiresan S, 2008, 11 SNPs, EUR) Triglycerides (Kathiresan S, 2008, 9 SNPs, EUR) Triglycerides (Kim YJ, 2011, 5 SNPs, ASN) Triglycerides (Kooner JS, 2008, 4 SNPs) Triglycerides (Pollin TI, 2008, 1 SNP, EUR) Triglycerides (Saxena R, 2007, 5 SNPs, EUR) Triglycerides (Tan A, 2011, 3 SNPs, ASN) Triglycerides (Teslovich TM, 2010, 32 SNPs, EUR) Triglycerides (Waterworth DM, 2010, 11 SNPs, EUR) Triglycerides (Willer CJ, 2008, 9 SNPs, EUR) Triglycerides-Blood Pressure (TG-BP) (Kraja AT, 2011, 6 SNPs, EUR) Tuberculosis (14 loci from 2 studies in AFR) Tuberculosis (Thye T, 2010, 14 SNPs, AFR) Tuberculosis (Thye T, 2012, 1 SNP, AFR) Tumor biomarkers (He M, 2013, 11 SNPs, ASN) Two-hour glucose challenge (Saxena R, 2010, 5 SNPs, EUR) Type 1 diabetes (70 loci from 9 studies in EUR) Type 1 diabetes (Barrett JC, 2009, 38 SNPs, EUR) Type 1 diabetes (Bradfield JP, 2011, 9 SNPs, EUR) Type 1 diabetes (Cooper JD, 2008, 14 SNPs, EUR) Type 1 diabetes (Grant SF, 2008, 5 SNPs, EUR) Type 1 diabetes (Hakonarson H, 2007, 4 SNPs, EUR) Type 1 diabetes (Hakonarson H, 2008, 1 SNP, EUR) Type 1 diabetes (Huang J, 2012, 2 SNPs, EUR) Type 1 diabetes (Todd JA, 2007, 12 SNPs, EUR) Type 1 diabetes (Wallace C, 2009, 2 SNPs, EUR) Type 1 diabetes (WTCCC, 2007, 10 SNPs, EUR) Type 1 diabetes autoantibodies (Plagnol V, 2011, 23 SNPs, EUR) Type 1 diabetes nephropathy (Sandholm N, 2012, 11 SNPs, EUR) Type 2 diabetes (53 loci from 11 studies in EUR) Type 2 diabetes (58 loci from 13 studies in ASN) Type 2 diabetes (6 loci from 2 studies in AMR) Type 2 diabetes (Below JE, 2011, 1 SNP, AMR) Type 2 diabetes (Cho YS, 2011, 10 SNPs, ASN) Type 2 diabetes (Cui B, 2011, 2 SNPs, ASN) Type 2 diabetes (dietary heme iron intake interaction) (Pasquale LR, 2013, 4 SNPs, EUR) Type 2 diabetes (Huang J, 2012, 1 SNP, EUR) Type 2 diabetes (Imamura M, 2012, 4 SNPs, ASN) Type 2 diabetes (Kho AN, 2011, 1 SNP, EUR) Type 2 diabetes (Kooner JS, 2011, 6 SNPs, ASN) Type 2 diabetes (Li H, 2012, 10 SNPs, ASN) Type 2 diabetes (Ma RC, 2013, 1 SNP, ASN) Type 2 diabetes (Palmer ND, 2012, 4 SNPs, AFR) Type 2 diabetes (Parra EJ, 2011, 5 SNPs, AMR) Type 2 diabetes (Perry JR, 2012, 12 SNPs, EUR) Type 2 diabetes (Qi L, 2010, 1 SNP, EUR) Type 2 diabetes (Salonen JT, 2007, 2 SNPs, EUR) Type 2 diabetes (Saxena R, 2007, 8 SNPs, EUR) Type 2 diabetes (Saxena R, 2013, 17 SNPs) Type 2 diabetes (Scott LJ, 2007, 10 SNPs, EUR) Type 2 diabetes (Shu XO, 2010, 4 SNPs, ASN) Type 2 diabetes (Sim X, 2011, 17 SNPs, ASN) Type 2 diabetes (Sladek R, 2007, 3 SNPs, EUR) Type 2 diabetes (Steinthorsdottir V, 2007, 3 SNPs, EUR) Type 2 diabetes (Tabassum R, 2012, 6 SNPs, EUR) Type 2 diabetes (Takeuchi F, 2009, 7 SNPs, ASN) Type 2 diabetes (Timpson NJ, 2008, 8 SNPs, EUR) Type 2 diabetes (Tsai FJ, 2010, 3 SNPs, ASN) Type 2 diabetes (Unoki H, 2008, 3 SNPs, ASN) Type 2 diabetes (Voight BF, 2010, 26 SNPs, EUR) Type 2 diabetes (WTCCC, 2007, 7 SNPs, EUR) Type 2 diabetes (Yamauchi T, 2010, 1 SNP, ASN) Type 2 diabetes (Yasuda K, 2008, 1 SNP, ASN) Type 2 diabetes (Zeggini E, 2007, 10 SNPs, EUR) Type 2 diabetes (Zeggini E, 2008, 16 SNPs, EUR) Type 2 diabetes and other traits (Rung J, 2009, 6 SNPs, EUR) Type 2 diabetes nephropathy (Maeda S, 2007, 1 SNP, ASN) Type 2 diabetes nephropathy (McDonough CW, 2010, 5 SNPs, AFR) Ulcerative colitis (11 loci from 2 studies in ASN) Ulcerative colitis (87 loci from 7 studies in EUR) Ulcerative colitis (Anderson CA, 2011, 47 SNPs, EUR) Ulcerative colitis (Asano K, 2009, 7 SNPs, ASN) Ulcerative colitis (Barrett JC, 2009, 13 SNPs, EUR) Ulcerative colitis (Franke A, 2008, 2 SNPs, EUR) Ulcerative colitis (Franke A, 2010, 6 SNPs, EUR) Ulcerative colitis (Haritunians T, 2010, 10 SNPs, EUR) Ulcerative colitis (Jostins L, 2012, 23 SNPs, EUR) Ulcerative colitis (McGovern DP, 2010, 19 SNPs, EUR) Ulcerative colitis (Silverberg MS, 2009, 12 SNPs, EUR) Ulcerative colitis (Yang SK, 2013, 8 SNPs, ASN) Upper aerodigestive tract cancers (McKay JD, 2011, 5 SNPs, EUR) Urate levels (48 loci from 2 studies in EUR) Urate levels (Dehghan A, 2008, 3 SNPs, EUR) Urate levels (Doring A, 2008, 1 SNP, EUR) Urate levels (Kamatani Y, 2010, 5 SNPs, ASN) Urate levels (Kottgen A, 2012, 47 SNPs, EUR) Urate levels (Li S, 2007, 1 SNP, EUR) Urate levels (Tin A, 2011, 5 SNPs, AFR) Urate levels (Vitart V, 2008, 1 SNP, EUR) Urate levels (Wallace C, 2008, 1 SNP, EUR) Urate levels (Yang Q, 2010, 11 SNPs, EUR) Uric acid levels (25 loci from 4 studies in EUR) Uric acid levels (Charles BA, 2011, 8 SNPs, AFR) Uric acid levels (Karns R, 2012, 6 SNPs, EUR) Uric acid levels (Kolz M, 2009, 11 SNPs, EUR) Uric acid levels (Li WD, 2013, 6 SNPs, EUR) Uric acid levels (McArdle PF, 2008, 7 SNPs, EUR) Urinary albumin excretion (3 loci from 2 studies in EUR) Urinary albumin excretion (Boger CA, 2011, 1 SNP, EUR) Urinary albumin excretion (Hwang SJ, 2007, 2 SNPs, EUR) Urinary bladder cancer (Kiemeney LA, 2008, 2 SNPs, EUR) Urinary bladder cancer (Kiemeney LA, 2010, 3 SNPs, EUR) Urinary metabolites (Suhre K, 2011, 5 SNPs, EUR) Urinary symptoms in response to radiotherapy in prostate cancer (Kerns SL, 2013, 1 SNP, EUR) Uterine fibroids (Cha PC, 2011, 5 SNPs, ASN) Vaccine-related adverse events (Miller EK, 2011, 2 SNPs, EUR) Vascular dementia (Kim Y, 2011, 1 SNP, ASN) Vascular endothelial growth factor levels (Debette S, 2011, 4 SNPs, EUR) Vaspin levels (Breitfeld J, 2012, 1 SNP, EUR) Venous thromboembolism (12 loci from 3 studies in EUR) Venous thromboembolism (gene x gene interaction) (Greliche N, 2013, 37 SNPs, EUR) Venous thromboembolism (Germain M, 2011, 4 SNPs, EUR) Venous thromboembolism (Heit JA, 2012, 5 SNPs, EUR) Venous thromboembolism (Tang W, 2013, 8 SNPs, EUR) Venous thromboembolism (Tregouet DA, 2009, 1 SNP, EUR) Ventricular conduction (Sotoodehnia N, 2010, 25 SNPs, EUR) Vertical cup-disc ratio (Ramdas WD, 2010, 9 SNPs, EUR) Visceral adipose tissue adjusted for BMI (Fox CS, 2012, 45 SNPs, EUR) Visceral adipose tissue/subcutaneous adipose tissue ratio (Fox CS, 2012, 42 SNPs, EUR) Visceral fat (Fox CS, 2012, 40 SNPs, EUR) Vitamin B12 levels (Hazra A, 2008, 1 SNP, EUR) Vitamin B12 levels (Lin X, 2012, 6 SNPs, ASN) Vitamin D insufficiency (Wang TJ, 2010, 3 SNPs, EUR) Vitamin D levels (Ahn J, 2010, 3 SNPs, EUR) Vitamin D levels (Lasky-Su J, 2012, 1 SNP, EUR) Vitamin E levels (Major JM, 2011, 3 SNPs, EUR) Vitiligo (29 loci from 4 studies in EUR) Vitiligo (8 loci from 2 studies in ASN) Vitiligo (Birlea SA, 2009, 4 SNPs, EUR) Vitiligo (Jin Y, 2010, 10 SNPs, EUR) Vitiligo (Jin Y, 2011, 1 SNP, EUR) Vitiligo (Jin Y, 2012, 14 SNPs, EUR) Vitiligo (non-segmental) (Cheong KA, 2013, 1 SNP, ASN) Vitiligo (Quan C, 2010, 4 SNPs, ASN) Vitiligo (Tang XF, 2012, 4 SNPs, ASN) Volumetric brain MRI (Seshadri S, 2007, 5 SNPs, EUR) vWF and FVIII levels (Antoni G, 2011, 11 SNPs, EUR) Waist circumference (9 loci from 2 studies in EUR) Waist circumference (Croteau-Chonka DC, 2010, 8 SNPs, ASN) Waist circumference (Fox CS, 2007, 2 SNPs, EUR) Waist circumference (Heard-Costa NL, 2009, 7 SNPs, EUR) Waist Circumference - Triglycerides (WC-TG) (Kraja AT, 2011, 7 SNPs, EUR) Waist circumference and related phenotypes (Chambers JC, 2008, 4 SNPs) Waist-hip ratio (17 loci from 2 studies in EUR) Waist-hip ratio (Berndt SI, 2013, 4 SNPs, EUR) Waist-hip ratio (Heid IM, 2010, 17 SNPs, EUR) Waist-to-hip circumference ratio (interaction) (Velez Edwards DR, 2012, 14 SNPs) Warfarin maintenance dose (Cha PC, 2010, 5 SNPs, ASN) Warfarin maintenance dose (Cooper GM, 2008, 3 SNPs) Warfarin maintenance dose (Perera MA, 2013, 1 SNP, AFR) Warfarin maintenance dose (Takeuchi F, 2009, 4 SNPs, EUR) Weight (26 loci from 2 studies in EUR) Weight (Croteau-Chonka DC, 2010, 7 SNPs, ASN) Weight (Johansson A, 2009, 9 SNPs, EUR) Weight (Thorleifsson G, 2008, 17 SNPs, EUR) Weight loss (gastric bypass surgery) (6 loci from 2 studies in EUR) Weight loss (gastric bypass surgery) (Hatoum IJ, 2013, 5 SNPs, EUR) Weight loss (gastric bypass surgery) (Rinella ES, 2013, 2 SNPs, EUR) White blood cell count (5 loci from 2 studies in AFR) White blood cell count (Crosslin DR, 2011, 3 SNPs, AFR) White blood cell count (Kamatani Y, 2010, 5 SNPs, ASN) White blood cell count (Nalls MA, 2011, 10 SNPs, EUR) White blood cell count (Reiner AP, 2011, 2 SNPs, AFR) White blood cell types (Okada Y, 2011, 20 SNPs, ASN) White matter hyperintensity burden (Fornage M, 2011, 2 SNPs, EUR) White matter integrity (interaction) (Sprooten E, 2012, 6 SNPs) White matter integrity (Lopez LM, 2012, 2 SNPs, EUR) White matter integrity (Sprooten E, 2012, 7 SNPs) Wilms tumor (Turnbull C, 2012, 7 SNPs, EUR) Working memory (McClay JL, 2010, 11 SNPs, EUR) Wrist bone mass (Tan L, 2010, 1 SNP, EUR) YKL-40 levels (Ober C, 2008, 1 SNP, EUR)